US20160114074A1 - Absorbent material - Google Patents

Absorbent material Download PDF

Info

Publication number
US20160114074A1
US20160114074A1 US14/941,906 US201514941906A US2016114074A1 US 20160114074 A1 US20160114074 A1 US 20160114074A1 US 201514941906 A US201514941906 A US 201514941906A US 2016114074 A1 US2016114074 A1 US 2016114074A1
Authority
US
United States
Prior art keywords
fiber
fabric
cellulose
woven absorbent
absorbent fabric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/941,906
Inventor
Stephen Law
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Speciality Fibres and Materials Ltd
Original Assignee
Speciality Fibres and Materials Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42224337&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20160114074(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0821675A external-priority patent/GB0821675D0/en
Priority claimed from EP08171355A external-priority patent/EP2196224A1/en
Application filed by Speciality Fibres and Materials Ltd filed Critical Speciality Fibres and Materials Ltd
Priority to US14/941,906 priority Critical patent/US20160114074A1/en
Assigned to SPECIALITY FIBRES AND MATERIALS LTD. reassignment SPECIALITY FIBRES AND MATERIALS LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LAW, STEPHEN
Publication of US20160114074A1 publication Critical patent/US20160114074A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/60Liquid-swellable gel-forming materials, e.g. super-absorbents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28Polysaccharides or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00Preparation of cellulose ethers
    • C08B11/02Alkyl or cycloalkyl ethers
    • C08B11/04Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00Preparation of cellulose ethers
    • C08B11/02Alkyl or cycloalkyl ethers
    • C08B11/04Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
    • C08B11/10Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08Cellulose derivatives
    • C08L1/26Cellulose ethers
    • C08L1/28Alkyl ethers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08Cellulose derivatives
    • C08L1/26Cellulose ethers
    • C08L1/28Alkyl ethers
    • C08L1/286Alkyl ethers substituted with acid radicals, e.g. carboxymethyl cellulose [CMC]
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/04Alginic acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/40Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
    • D04H1/42Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/40Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
    • D04H1/42Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece
    • D04H1/425Cellulose series
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/40Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
    • D04H1/42Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece
    • D04H1/425Cellulose series
    • D04H1/4258Regenerated cellulose series
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/40Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
    • D04H1/42Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece
    • D04H1/4282Addition polymers
    • D04H1/4291Olefin series
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/40Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
    • D04H1/42Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece
    • D04H1/4382Stretched reticular film fibres; Composite fibres; Mixed fibres; Ultrafine fibres; Fibres for artificial leather
    • D04H1/43825Composite fibres
    • D04H1/43828Composite fibres sheath-core
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/40Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
    • D04H1/42Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece
    • D04H1/4382Stretched reticular film fibres; Composite fibres; Mixed fibres; Ultrafine fibres; Fibres for artificial leather
    • D04H1/43835Mixed fibres, e.g. at least two chemically different fibres or fibre blends
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/40Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
    • D04H1/44Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties the fleeces or layers being consolidated by mechanical means, e.g. by rolling
    • D04H1/46Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties the fleeces or layers being consolidated by mechanical means, e.g. by rolling by needling or like operations to cause entanglement of fibres
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/70Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
    • D04H1/72Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
    • D04H1/736Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged characterised by the apparatus for arranging fibres
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2205/00Polymer mixtures characterised by other features
    • C08L2205/14Polymer mixtures characterised by other features containing polymeric additives characterised by shape
    • C08L2205/16Fibres; Fibrils
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/40Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
    • D04H1/42Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece
    • D04H1/4382Stretched reticular film fibres; Composite fibres; Mixed fibres; Ultrafine fibres; Fibres for artificial leather
    • D04H1/43825Composite fibres
    • D04H1/43832Composite fibres side-by-side
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/249921Web or sheet containing structurally defined element or component

Definitions

  • Absorbent fibers useful as components in advanced wound care dressings are known in the art, particularly fibers based on alginic acid, carboxymethylcellulose, and carboxymethylchitosan, and salts thereof.
  • Dressings based on fibers of alginic acid or its salts have good overall absorbency of wound fluid, but suffer from slow absorption due to the need to exchange multivalent ions binding the fibrous structure together with sodium ions present in wound fluid. Although this ion exchange renders the fibers swellable in ion containing aqueous media, allowing significant absorption of fluid, the mechanical strength of the gelled fibers is compromised, and it is not routinely possible to remove a saturated dressing in one piece. Frequently, the dressing must be irrigated with saline to wash it away, and this can be traumatic for the patient.
  • Carboxymethyl cellulose fibers have also been used as the main component in advanced wound care dressings, and these too have significant absorptive capacity for wound fluid.
  • Their advantage over alginate-type dressings is that absorption of fluid is virtually instantaneous since no ionic exchange is required to render the fibers gellable.
  • those fibers based on a highly crystalline cellulose, such as lyocell, and in particular those described in EP0616650 and EP0680344 tend to retain a higher level of mechanical strength and therefore may be removed from the wound site in one piece.
  • the absorptive capacity of this class of material is strongly dependent on the pH of the wound fluid, reducing dramatically at acidic pH.
  • an absorbent dressing it is desirable for an absorbent dressing to perform well at acidic pH, and preferably for it to perform well over a wide range of pH. Since absorbent dressings based on carboxymethylcellulose do not perform well in low pH environments, there is a need for an instantly gelling, absorptive dressing that continues to absorb to a good level at reduced pH.
  • absorbent fibers for use in absorbent dressings it is desirable for absorbent fibers for use in absorbent dressings to be obtained from a renewable resource, to be inexpensive and also biodegradable.
  • cellulose a renewable and biodegradable source of absorbent material.
  • U.S. southern pine fluff pulp is used as an absorbent material in the personal care industry.
  • other absorbent materials and commonly materials that are not renewable and biodegradable, for example acrylic acid polymers. The reason for this is that absorbed liquid is not effectively retained in materials that are made exclusively of cellulosic fibers.
  • the cellulose fiber can be modified by sulfonation, for example by substitution with an alkyl sulfonate at one or more of the hydroxyl groups on the anhydroglucose monomers that make up the cellulose backbone, forming ether linkages.
  • Cellulose derivatives of this type are known as cellulose sulfonates or cellulose alkyl sulfonates.
  • cellulose ethers are, as a rule, water-soluble compounds.
  • cellulose ethyl sulfonate is known to be water-soluble.
  • Cellulose ether sulfonates have been modified further in order to produce water insoluble products.
  • Glasser et al. U.S. Published Patent Application No. 2006/0142560 refers to absorbent fibers based on mixed cellulose alkylsulfonates in which the cellulose is substituted by two different groups, an alkyl sulfonate and a hydroxyalkyl sulfonate, specifically ethyl sulfonate and 2-hydroxypropyl sulfonate. Water insolubility of the modified cellulose is believed to result from the presence of the 2-hydroxypropyl sulfonate group.
  • Shet et al., U.S. Pat. No. 5,703,225 refers to a water-insoluble sulfonated cellulose that is a hydroxy sulfonic cellulose in which both the sulfur atom of a sulfonic group and a hydroxyl group are directly attached to a carbon atom on the cellulose chain.
  • absorbent materials To be suitable for use in wound dressings, absorbent materials must retain their integrity and hence be water-insoluble.
  • the principal disadvantage of the water insoluble cellulose alkyl sulfonates that have been developed for use as absorbent materials to date is the requirement for substitution of the cellulose with at least two different groups. Compared to substitution with a single substituent, additional reactants and additional processing steps are not desirable, and are likely to increase the cost of manufacture. Furthermore, as the cellulose is increasingly modified, benefits associated with the natural fiber, such as its biodegradability, may be impaired.
  • water-insoluble cellulose alkyl sulfonates may be prepared by the substitution of cellulose with only one type of alkyl sulfonate.
  • chitin and chitosan are natural polysaccharides based on D-glucosamine units, which have hydroxyl groups at positions at C3 and C5 where reaction substitution with alkyl sulfonate groups can take place.
  • an absorbent article comprising as an absorbent material, a water-insoluble polysaccharide alkyl sulfonate, wherein the polysaccharide is substituted with one type of alkyl sulfonate.
  • the modified polysaccharides of the invention are highly advantageous for use as absorbent materials in wound dressings because they exhibit excellent absorption and retention of fluid while maintaining their integrity sufficiently to be removed from the wound site in one piece, without irrigation, and with minimum pain and shedding.
  • absorption of fluid is virtually instantaneous since ionic exchange is not required for the fibers to become gellable.
  • the water-soluble polysaccharide alkyl sulfonates of the present invention are advantageous compared to carboxymethyl cellulose because the absorptive capacity may be affected to a lesser extent by changes in pH. Wound dressings containing these materials may continue to absorb to a good level at low pH.
  • the polysaccharide alkyl sulfonate may be used in the form of fibers.
  • the polysaccharide alkyl sulfonate may be a cellulose alkyl sulfonate, and the following description refers primarily to such embodiments of the invention. It will be appreciated, however, that other polysaccharides may be utilized.
  • the alkyl moiety of the alkyl sulfonate substituent group is preferably a lower alkyl having 1 to 6 carbon atoms, preferably methyl, ethyl, propyl, or butyl.
  • the alkyl moiety may be branched or unbranched, and hence suitable propyl sulfonate substituents may be 1- or 2-methyl-ethylsulfonate.
  • Butyl sulfonate substituents may be 2-ethyl-ethylsulfonate, 2,2-dimethyl-ethylsulfonate, or 1,2-dimethyl-ethylsulfonate.
  • the alkyl sulfonate substituent group that is most preferred is ethyl sulfonate.
  • a preferred cellulose alkyl sulfonate of the present invention is cellulose ethyl sulfonate, where ethyl sulfonate or one of its salts is attached via one or more of the hydroxyl groups on the anhydroglucose units of the cellulose.
  • the structure of one anhydroglucose unit substituted by one ethyl sulfonate group is depicted by formula (I)
  • Formula (I) is not meant to depict the exact chemical structure of cellulose ethyl sulfonate prepared in accordance with the invention, because substitution can take place at any of the hydroxyl positions in the cellulose macromolecule, in any distribution up to the maximum degree of substitution that is possible.
  • the average degree of substitution refers to the mean number of hydroxyl positions substituted with an alkyl sulfonate substituent group, or put another way, the mean number of moles of alkyl sulfonate groups per mole of anhydroglucose unit in the cellulose polymer.
  • the maximum degree of substitution is therefore 3, when the anhydroglucose unit is substituted at all three hydroxyl positions.
  • the degree of substitution when an average of one hydroxyl group is substituted per anhydroglucose unit, as shown in Formula (I), is 1.
  • Cellulose ethyl sulfonate is described in the prior art as a water-soluble compound, and is modified further to render it water-insoluble, e.g., by alkylation with 3-chloro-2 hydroxypropyl sulfonate.
  • Water insoluble cellulose ethyl sulfonate and other insoluble cellulose alkyl sulfonates wherein the cellulose is substituted with one type of alkyl sulfonate are therefore believed to be novel.
  • a water-insoluble cellulose alkyl sulfonate wherein the cellulose is substituted with one type of alkyl sulfonate.
  • the functional properties of the cellulose alkyl sulfonates of the present invention depend on the degree of substitution, the chain length of the cellulose backbone structure, and the structure of the alkyl sulfonate substituent. Solubility and absorbency are largely dependent on the degree of substitution: as the degree of substitution is increased, the cellulose alkyl sulfonate becomes increasingly soluble. It follows that, as solubility increases, absorbency increases.
  • the fibers of the absorbent material preferably have an absorbency of at least 8 grams per gram (g/g) of 0.9% saline solution, as measured by the method described below in Example 1.
  • the fibers of the preferred cellulose alkyl sulfonates of the present invention have an absorbency (of 0.9% saline solution) of at least 8 g/g, more preferably at least 9 g/g, most preferably at least 10 g/g.
  • a fabric material comprising cellulose alkyl sulfonate fibers with a fabric absorbency greater than 2 g/g provides for a good contact layer dressing as the fibers absorb sufficient exudate, thus forming a gelled material to provide a non-adhesive surface.
  • cellulose alkyl sulfonates of the present invention have an absorbency (of 0.9% saline solution) of greater than 2 g/g, 4 g/g, or 6 g/g.
  • the average degree of substitution should preferably be less than 0.4 for the cellulose alkyl sulfonate to be substantially water-insoluble.
  • substantially is meant in this context that when the cellulose alkyl sulfonate is exposed to an excess of an aqueous medium it does not dissolve into solution, or at least that dissolution is so low as to have no significant effect on the properties of the polymer.
  • the average degree of substitution is preferably less than 0.4, more preferably less than 0.3.
  • the average degree of substitution of the cellulose alkyl sulfonate is from about 0.05 to about 0.4, more preferably from about 0.1 to about 0.3.
  • Cellulose alkyl sulfonates with alkyl group having 2 to 6 carbon atoms can be formed by reaction of cellulose with an alkenyl sulfonate or one of its salts in the presence of a base, preferably an alkali metal hydroxide, either in aqueous or non-aqueous medium.
  • Cellulose alkyl sulfonate with 1 carbon atom i.e., cellulose methylsulfonate
  • Alkalization and alkyl sulfonation may be carried out as a single step in which the base and alkenyl sulfonate or chloromethylsulfonate are added at the same time in one reaction vessel (a “one-pot” process).
  • alkalization and alkyl sulfonation may be carried out in two separate reaction steps, treating the cellulose first with alkali and then alkyl sulfonating agent, or with alkyl sulfonating agent and then alkali.
  • One-pot processes are often desirable because they can be easier, quicker, and by minimizing the number of reaction steps a higher yield may be obtained.
  • the reaction rate is higher than that observed for the equivalent reaction in which alkalization and alkyl sulfonation are carried out in separate steps.
  • the greater the degree of substitution the greater the absorbency of the cellulose alkyl sulfonate material.
  • the reaction rate may be determined by measuring the time taken for the alkyl sulfonation reaction to yield a product having a particular degree of absorbency. In practice, it is not easy to stop a reaction at a specific absorbency level. Nevertheless, it is clear that a reaction taking 90 minutes to reach an absorbency of 14.2 g/g is significantly faster than one that takes 120 minutes to reach an absorbency of only 9.7 g/g.
  • the amount of water in the reaction mixture is also shown to affect the reaction rate. Lowering the water content in a reaction in which alkalization and alkyl sulfonation are carried out simultaneously results in a significant increase in reaction rate. Lowering the water content in the alkyl sulfonation step of a reaction in which alkalization and alkyl sulfonation are carried out separately increases the rate, but to a lesser extent.
  • a one-pot process would also be expected to minimize exposure of the cellulose to the base, therefore keeping the alkaline, oxidative degeneration of the cellulose to a minimum. It is necessary to minimize degeneration of the cellulose during processing in order to ensure that the modified cellulose is sufficiently strong to be useful as an absorbent material in a wound dressing, and indeed to maximize both the dry strength and the wet strength of the product.
  • the strength of the fibers prepared by a one-pot process may be surprisingly and significantly weaker than fibers prepared by carrying out alkalization and alkyl sulfonation in separate steps, depending on the level of water used in the reaction mixture.
  • the cellulose alkyl sulfonates produced by a one-pot process have a surprisingly low fiber strength compared to the cellulose alkyl sulfonates produced by the analogous two-step process.
  • the fibers are too weak to be suitable for processing using normal non-woven textile processing methods. If the level of water used in the reaction is reduced, the reaction rate increases and also the fiber strength increases to a useable level.
  • a process for the preparation of water-insoluble cellulose alkyl sulfonate comprising the simultaneous reaction of cellulose with an alkali and alkyl sulfonating agent, and wherein the weight of water present in the reaction is less than 1030%, preferably less than 1015%, preferably less than 950%, of the (dry) weight of the cellulose.
  • Fiber absorbencies average about 15 g/g at 1027% water on a dry weight basis.
  • step (b) reacting the product of step (a) with an alkenyl sulfonate or its salt, or chloromethane sulfonic acid or its salt;
  • step (c) isolating the product of step (b).
  • step (b) This two-step process is surprisingly beneficial when the level of water used in step (b) is more than 950% of the (dry) weight of the cellulose.
  • an absorbent article comprising the cellulose alkyl sulfonate fibers.
  • the absorbent article When fully hydrated, the absorbent article is substantially transparent. This is advantageous in wound care applications since the state of the underlying wound can be determined without removing the dressing.
  • the present invention is directed to an absorbent fabric article comprising cellulose alkyl sulfonate of the present invention which is reinforced with a reinforcing fiber blended or bonded to the water-insoluble polysaccharide alkyl sulfonate.
  • the use of sheath/core bicomponent fibers is particularly advantageous because the sheath material melts at a lower temperature than the core so on bonding leaves a strong, unmelted core superstructure.
  • thermoplastic bicomponent fibers based on polyolefins preferably a polypropylene core/polyethylene sheath
  • polyolefins preferably a polypropylene core/polyethylene sheath
  • the absorbency of the resultant fabric is not compromised by the substantially non-absorbent, hydrophobic reinforcing component.
  • using a reinforcing fiber having a lower linear density allows for a reduction in the weight amount of the fibers, resulting in increased transparency of the absorbent article.
  • the absorbent fabric articles comprising the cellulose alkyl sulfonate of the present invention exhibit an absorbency of at least 15 g/g using a sodium/calcium test solution.
  • Absorbency is preferably not compromised using a reinforcing fiber, while wet strength is improved.
  • the absorbency of the composite product comprising the cellulose alkyl sulfonate fibers and the reinforcing fibers is preferably at least 15, 16, 17, 18, 19, or 20 g/g using the sodium/calcium test solution.
  • the wet strength of the composite product is preferably at least 1, 2, 3, 4, 5, or 6 N/cm when using a sodium calcium test solution and Instron tensile testing machine as provided herein.
  • one or more antimicrobial agents are applied to the polysaccharide alkyl sulfonate fibers and absorbent articles of the present invention.
  • Preferred agents include silver and/or polyhexamethylene biguanide (“PHMB”).
  • the weight of the silver cation in the product is preferably about 0.5 to 5 wt %, preferably about 1 to 3 wt %, and still more preferably about 1.5 to 2.0 wt %.
  • the weight of PHMB is preferably about 0.1 to 1%, and is preferably about 0.5 to 0.7 wt %.
  • FIG. 1 shows the absorbency of cellulose ethyl sulfonate (“CES”) fibers of the present invention comparable to carboxymethyl cellulose (“MC”) fibers as described in Example 8.
  • CES cellulose ethyl sulfonate
  • Comparable amounts of water were used in the two-step high water reaction and the one-pot high water reaction.
  • the reaction rate of the one-pot process was significantly higher, but the filament strength of the cellulose ethyl sulfonate product produced by the one-pot process was lower than the strength of the fiber produced by the two-step process with separate alkalization and alkyl sulfonation steps. Indeed, the filament strength of the product of the one-pot process was too low for the material to be effective for use, as intended, in wound dressing applications.
  • the weight of water present in the reaction is less than 1050% of the (dry) weight of the cellulose, more preferably less than 950% of the weight of the cellulose, still more preferably less than 800% of the weight of the cellulose, more preferably less than 700% by weight of the cellulose, and most preferably less than 650% by weight of the cellulose.
  • Reducing the level of water in the second alkyl sulfonation step in the two-step process is shown to increase the reaction rate.
  • it is not always practicable to carry out that reaction step using lower levels of water as it becomes increasingly difficult to wet the cellulose as the volume of alkyl sulfonate reactant decreases.
  • the one-pot process is preferred.
  • the two-step process is most suitable for producing cellulose alkyl sulfonates of the present invention with adequate fiber strength.
  • the weight of water present in the alkyl sulfonation step is more than 650% by (dry) weight of the cellulose, more preferably more than 750% by weight of the cellulose, more preferably more than 850% by weight of the cellulose, and most preferably more than 950% by weight of the cellulose.
  • the cellulose is preferably fibrous in nature.
  • the cellulose fibers should have a high degree of crystallinity and total orientation in order that the fibers maintain sufficient strength after derivatization to be processed, and that the resulting material is strong enough for its intended use.
  • the use of alkali in the alkalization step can degrade the cellulose backbone, causing chain scission and a reduction in the degree of polymerization, thereby resulting in the fibers having a lower strength after derivatization.
  • the dry strength of the derivatized fibers must be sufficient to enable processing into woven or nonwoven structures, and, to be useful as an absorbent material in a wound dressing, the wet strength of the material must be sufficient to allow removal from the site in one piece.
  • Fibrous celluloses with a high degree of crystallinity that are particularly suitable for use in the invention, include cotton or regenerated cellulose fibers such as lyocell.
  • the cellulose may be alkalized by treatment with a strong alkali, preferably an alkali metal hydroxide such as sodium hydroxide.
  • a strong alkali preferably an alkali metal hydroxide such as sodium hydroxide.
  • a 47% sodium hydroxide solution has been found to be suitable.
  • the strength of the reaction conditions should be balanced with the need to avoid degradation of the cellulose substrate.
  • the level of degradation of the cellulose is considerably lower than might be expected under the relatively intense reaction conditions that are required for alkalization.
  • it may be beneficial to remove excess alkali before proceeding with second alkyl sulfonation step e.g., by mechanically squeezing the alkalized fibers.
  • the reaction involves the nucleophilic addition of the alkoxide ion to an alkenyl sulfonate, specifically ⁇ -alkenyl sulfonate or its salt.
  • the ⁇ -alkenyl sulfonate is preferably a lower alkenyl sulfonate, in which the alkenyl moiety has 2 to 6 carbon atoms.
  • the ⁇ -alkenyl sulfonate is vinyl sulfonate, allyl sulfonate (1-propenyl sulfonate), isopropenyl sulfonate (1-methylvinyl sulfonate), 1-butenyl sulfonate, 1-methyl allyl sulfonate (1-methyl-1-propenyl sulfonate) or 2 methylallyl sulfonate (2-methyl-1-propenyl sulfonate).
  • the ⁇ -alkenyl sulfonate is vinyl sulfonate, more preferably the sodium salt of vinyl sulfonate, and hence the cellulose alkyl sulfonate product is cellulose ethyl sulfonate.
  • the sodium salt of vinyl sulfonate is commercially available as an approximately 30% aqueous solution. It may be brought into contact with the cellulose or alkalized cellulose by methods known in the art, for instance spraying onto the cellulose, or mixing using stirrers.
  • the conversion to cellulose alkyl sulfonate can take place at any temperature up to the boiling point of the reaction mixture, or beyond it if a pressurized system is used.
  • the rate of reaction is increased if the reaction stage is carried out at elevated temperature.
  • the preferred range is 30-95° C. to give a useful degree of substitution in an economic time.
  • fresh charges of reactant can be introduced at any time throughout the reaction.
  • the degree of substitution can be controlled by control of reaction temperature and, in particular, by control of the reaction time.
  • Vinyl sulfonate is thought to be less hazardous than some of the halogenated reactants, particularly chlorinated reactants, which are typically used to prepare the absorbent materials currently available for use in wound care products.
  • chlorinated reactants particularly chlorinated reactants
  • chloroacetic acid used in the manufacture of carboxymethyl cellulose, is a potentially dangerous alkylating agent. Its use during the manufacturing process is undesirable, and retention of any residual chloroacetic acid in the absorbent product may be harmful, at the least causing skin irritation.
  • alkyl sulfonate also presents potential advantages in terms of safety and removal of residual reactant compared to other water-insoluble cellulose alkyl sulfonates that are known, in which the cellulose is substituted with more than one type of alkyl sulfonate, if only because of the relative simplicity of the chemistry.
  • the reaction can be stopped by neutralizing the reaction mixture, i.e., reducing the pH to approximately neutral by addition of acid.
  • the acid may be any common mineral or organic acid such as hydrochloric or acetic acid, respectively.
  • the cellulose alkyl sulfonate product can then be washed free of by-products and impurities by employing washing stages known in the art. Such stages include washing with water, organic liquids, or mixtures thereof. Particularly useful are mixtures of a lower alcohol and water. Washing efficiency can be enhanced by washing at elevated temperature. After washing, it may be desirable to apply a processing aid, such as glycerol, as is common practice in the production of, for example, cellulose film (cellophane). This can be achieved by methods known in the art, such as dipping, spraying etc.
  • the derivatized cellulose article should be dried to remove residual liquid from the previous stages. Drying can be carried out by methods known in the art such as forced air drying, radiant heat drying etc.
  • the absorbent materials of the present invention exhibit instant gelling in aqueous media, good absorbency and, crucially, good retention of absorbency in an acidic environment. This renders them ideal for use as an absorbent wound dressing, or as part of an absorbent dressing. They are particularly useful for wounds with moderate to high levels of exudates, and for flat or cavity wounds of this type. Typical examples include pressure sores and leg ulcers.
  • absorbent materials of the present invention is not limited to wound care products, and they are expected to be useful for many other applications.
  • the simplicity of the chemistry and the availability of the reactants enable the cost of manufacture of such articles to be kept advantageously low.
  • the cellulose alkyl sulfonates of the present invention may be processed according to known methods into a wide variety of forms, depending on their intended use.
  • the manner in which the derivative cellulose is processed has a significant effect on the properties of the final product, particularly the strength, gelling time, and absorbency.
  • Preferred cellulose alkyl sulfonate products for use in wound care articles are carded, needle-bonded nonwovens.
  • the cellulose alkyl sulfonates may be combined with one or more reinforcing fibers as generally set forth in Hansen, U.S. Pat. No. 5,981,410 titled “Cellulose-Binding Fibres”; Stengaard et al., U.S. Pat. No. 6,811,716 titled “Polyolefin Fibers and Method for the Production Thereof”, Jensen et al., U.S. Pat. No. 5,958,806 titled “Cardable Hydrophobic Polyolefin Fibres Comprising Cationic Spin Finishes;” all of which are incorporated by reference.
  • Preferred reinforcing fibers are thermoplastic biocomponent fibers, most preferably having a polyolefin component.
  • the fibers preferably comprise a polyolefin-containing polymeric material of which the largest part (by weight) consists of homo- or copolymers of monoolefins such as ethylene, propylene, 1-butene, 4-methyl-1-pentene, etc.
  • Examples of such polymers are isotactic or syndiotactic polypropylene, polyethylenes of different densities, such as high density polyethylene, low density polyethylene, and linear low density polyethylene and blends of the same.
  • the polymeric material may be mixed with other non-polyolefin polymers such as polyamide or polyester, provided that polyolefins still constitute the largest part of the composition.
  • the melts used to produce the polyolefin-containing fibers may also contain various conventional fiber additives, such as calcium stearate, antioxidants, process stabilizers, compatibilizers, and pigments.
  • Methods for applying the thermoplastic biocomponent fibers are described in EP0740554; EP0171806; Ejima et al., U.S. Pat. No. 5,456,982; Davies, U.S. Pat. No. 4,189,338; Davies, U.S. Pat. No. 3,511,747; and Reitboeck et al., U.S. Pat. No. 3,597,731, which are incorporated by reference.
  • thermoplastic bicomponent fibers may be of the sheath-core type with the core being located either eccentrically (off-center) or concentrically (substantially in the center), or of the side-by-side type, in which each of the two components typically has a semi-circle cross section.
  • Bicomponent fibers having irregular fiber profiles are also contemplated, e.g., an oval, ellipse, delta, star, multilobal, or other irregular cross section, as well as splittable fibers.
  • the bicomponent fibers will typically have a high melting and low melting polyolefin component which comprise, respectively, polypropylene/polyethylene (the polyethylene comprising HDPE, LDPE, and/or LLDPE), high density polyethylene/linear low density polyethylene, polypropylene random copolymer/polyethylene, or polypropylene/polypropylene random copolymer.
  • polypropylene/polyethylene the polyethylene comprising HDPE, LDPE, and/or LLDPE
  • high density polyethylene/linear low density polyethylene polypropylene random copolymer/polyethylene
  • polypropylene/polypropylene random copolymer polypropylene/polypropylene random copolymer.
  • Preferred thermoplastic biocomponent fibers are commercially available from Fiber Visions (Athens, Ga.). Suitable thermoplastic biocomponent fibers comprise 30, 25, 20, 18, 16, 14, 12, 10, 8, 6, or 4 wt % or any range there between of the composite absorbent article.
  • thermoplastic biocomponent fibers preferably have a linear density of about 1.7, 1.9, 2.1, 2.3, 2.4, 2.6, 2.8, 3.0, 3.2, 3.4, 3.8, 4.0, 4.2, 4.4, 4.6, 4.8, 5.0 decitex up to 16.7 decitex or any range therebetween.
  • high-density fibers e.g., 4.0 decitex
  • the absorbency of the article is not compromised.
  • using a reinforcing fiber having a lower linear density allows for a reduction in the weight amount of the fibers, resulting in increased transparency.
  • the thermoplastic biocomponent fibers preferably comprise about 10 to 30 wt % (more preferably about 10 to 20%, and still more preferably about 10 to 13%) of the absorbent article and have a linear density of about 1.7 to 4.0 decitex (more preferably about 1.7 to 1.9 decitex).
  • the temperature used to fuse the fibers together is typically in the range of 90 to 162° C., preferably about 120 to 125° C.
  • the reinforcing fibers comprise lyocell fibers.
  • These fibers generally comprise a cellulose obtained by an organic solvent spinning process.
  • the lyocell fiber is generated from cellulose fibers using various amine oxides as solvents.
  • N-methylmorpholine-N-oxide (“NMNO”) with water (about 12%) proves to be a particularly useful solvent. Examples of processes for preparing lyocell fibers are described in McCorsley et al., U.S. Pat. Nos. 4,142,913; 4,144,080; 4,211,574; 4,246,221; and 4,416,698, and others. Jurkovic et al., U.S. Pat. No.
  • lyocell product produced by Lenzing is presently commercially available as TENCEL® fiber.
  • the methods for including these cellulose fibers into nonwoven structures to aid in integrity of the product is well known, see, e.g., GB1207352, which is incorporated by reference.
  • the lyocell fibers comprise 26, 24, 22, 20, 18, 16, 14, 12, 10, 8, 6, or 4 wt % or any range therebetween of the composite absorbent article.
  • the lyocell fibers preferably have a linear density of about 0.7, 0.9, 1.1, 1.3, 1.5, 1.7, 1.9, 2.1, 2.3, 2.4, 2.6, 2.8, 3.0, 3.2, 3.4, 3.8, 4.0, 4.2, 4.4, 4.6, 4.8, 5.0, 10, 15, 20, 25, up to 30 decitex or any range therebetween.
  • low density fibers e.g., about 1.2 to 1.6 decitex
  • high levels e.g., about 10 to 30 wt %, preferably about 10 to 20 wt %
  • one or more antimicrobial agents are applied to the cellulose alkyl sulfonate of the present invention.
  • Preferred agents include silver and/or polyhexamethylene biguanide (“PHMB”).
  • the present invention is also directed to a novel method for applying a metal ion to a hydrophilic, amphoteric, or anionic polymer, especially those used in a medical device, a wound dressing, or an ostomy device.
  • Materials which are particularly adapted for the inventive method include gel-forming fibers such as AQUACEL® (WO 93/12275, WO 94/16746, WO 99/64079, and U.S. Pat. No. 5,731,083), or those described in WO 00/01425 or PCT/GB 01/03147; wound dressings containing similar gel-forming fibers behind or overlying a non-continuous or perforated skin-contact layer such as VERSIVA® (U.S. Pat. No.
  • Polymers suitable for the present invention include, but are not limited to, polysaccharides or modified polysaccharides, polyvinylpyrrolidone, polyvinyl alcohols, polyvinyl ethers, polyurethanes, polyacrylates, polyacrylamides, collagen, gelatin, or mixtures thereof.
  • the polymers contain carboxymethylcellulose such as sodium carboxymethylcellulose.
  • the polymer can be a polysaccharide comprising a carboxymethylcellulose or alginate, or a mixture of carboxymethylcellulose and alginate.
  • the coating step is most preferably used with the cellulose alkyl sulfonate of the present invention.
  • the fiber was cut into a 2-3 mm flock, and 0.5 g of cut fiber was placed in a 100 ml screw-top jar. 50 ml of test liquid (e.g., 0.9% saline, typically used to simulate the ionic strength of wound fluid) was added, and the jar shaken for 30 seconds to disperse the flock. The dispersion was then filtered through a 47 mm Buchner funnel fitted with a 42.5 mm diameter Whatman No. 4 filter paper, using a vacuum pump, with vacuum set to be greater than 0.8 bar for one minute. Then the fiber dispersion was removed and weighed. Fiber free absorbency was calculated using the following formula:
  • Tenacity and elongation at break of dry, single filaments was carried out using a tensile testing machine, fitted with appropriate jaws for gripping single filaments and load cell of the appropriate range.
  • the samples were conditioned for at least four hours and were tested in the standard atmosphere for testing textiles (20 ⁇ 2° C. and 65 ⁇ 2% relative humidity).
  • the machine was balanced and calibrated according to the manufacturer's instructions. Filaments were taken at random from different parts of the sample. The linear density of the filament was measured by an appropriate technique such the Vibraskop method. The filament was then placed between the jaws of the tensile testing machine and the test started. The following conditions were used:
  • breaking load (cN) and the breaking extension (%) of each filament was usually printed out together with the statistics.
  • individual breaking loads being printed out, individual tenacity results or a mean tenacity were calculated by hand, as follows:
  • a 3 g sample of lyocell tow known under the tradename TENCEL® (manufactured by Lenzing), was immersed in aqueous 47% sodium hydroxide for 25 minutes at 25° C. Excess sodium hydroxide was then removed by squeezing. Then 25 ml 30% sodium vinyl sulfonate solution (Fluka Chemicals) was added to the fiber and heated at 91° C. for 90 minutes. After this time the reaction mixture was neutralized to pH 7 by adding glacial acetic acid dropwise. Then the excess liquid was squeezed from the fiber, and the fiber was washed twice in a mixture of industrial methylated spirit (“IMS”) and water (80:20 v/v). After drying to constant weight at 60° C., the fiber was tested for absorbency.
  • IMS industrial methylated spirit
  • Example 2 Using the method outlined in Example 1, and an aqueous solution of 0.9% NaCl as the test liquid, an fiber free absorbency value of 11.1 g/g was achieved.
  • TENCEL® fiber A 2.5 g sample of TENCEL® fiber was immersed in 47% sodium hydroxide for 30 minutes at 20° C., after which excess liquid was removed by squeezing. 21 ml sodium vinyl sulfonate (30% aqueous solution) was poured over the fiber. The vessel containing fiber and reactant was then heated at 83° C. for two hours, after which time the sample was neutralized by the dropwise addition of glacial acetic acid until a pH of 7 was reached. The excess liquid was then squeezed from the fiber, and the fiber was washed twice with IMS/water (80:20 v/v), and finally in 100% IMS. After drying to constant weight at 60° C., the fiber was tested for absorbency according to the method in Example 1, using 0.9% aqueous NaCl as the test liquid. A fiber free absorbency value of 9.7 g/g was obtained.
  • TENCEL® fiber was immersed in a mixture of 10 ml 47% NaOH and 25 ml 30% sodium vinylsulfonate solution, and heated for 75 minutes at 83° C. The reaction mixture was then neutralized by addition of acetic acid, after which the fiber was removed and washed in a mixture of IMS/water (80:20 v/v), and finally in 100% IMS. Drying was carried out at 60° C.
  • Example 2 Using the method outlined in Example 1, and an aqueous solution of 0.9% NaCl as the absorbent test liquid, a fiber free absorbency value of 6.6 g/g was achieved. The fibers were visibly weaker than the fibers of Example 6, despite having a lower degree of substitution, as evidenced by the lower absorbency value.
  • TENCEL® fiber was immersed in a mixture of 13 ml 30% sodium vinylsulfonate solution and 10 ml 47% NaOH solution, and heated for 70 minutes at 83° C. The reaction mixture was then neutralized by addition of acetic acid, after which the fiber was removed and washed in a mixture of IMS/water (80:20 v/v), and finally in 100% IMS. Drying was carried out at 60° C.
  • TENCEL® fiber from the same batch used as the starting material for Examples 3 and 4 was subjected to the absorbency test outlined in Example 1, using 0.9% aqueous NaCl as the absorbent test liquid. A fiber free absorbency value of 0.9 g/g was obtained.
  • CMC carboxymethyl cellulose
  • Cellulose ethyl sulfonate fibers were produced according to the present invention from lyocell fiber, and their absorbency measured in the same way at a range of pH values.
  • cellulose ethyl sulfonate fiber made according to the present invention to was cut to 50 mm staple and blended in a 20% by weight proportion with 4.0 decitex 40 mm staple bicomponent fiber (ES-LOWMELTTM manufactured by Fiber Visions) through a sample card.
  • the resulting web was needlebonded, and then thermally bonded by heating in a recirculating oven set at 125° C. for 10 minutes.
  • Comparative cellulose ethyl sulfonate fabric containing no reinforcing fiber was manufactured in a similar manner, without a thermal bonding step.
  • the wet strength was measured by cutting test specimens 2.5 cm wide ⁇ 10 cm long from the fabric.
  • the sample was mounted in an Instron 3343 tensile testing machine to give a gauge length 5 cm.
  • the sample was then wetted with 2.5 ml of solution A (sodium/calcium solution), left for one minute, and then tested at 100 mm/min.
  • the sodium/calcium Solution A is formed by dissolving 16.6 g of NaCl and 0.74 g of CaCl dihydrate in 2 L of water.
  • the clarity measured subjectively by placing beneath a gelled (0.9% saline hydrated) sample printed bold type face 12 pt Times New Roman and subjectively scoring the clarity from 0 (completely opaque, typeface not visible) to 10 (completely clear, undistorted typeface).
  • the absorbency was measured by weighing a 5 cm ⁇ 5 cm square of sample material (W 1 ). Next, the sample was placed in Solution A at 37° C. for 30 minutes in a petri-dish. Then the square was lifted out of the petri-dish by holding the square by one corner, and the sample was allowed to drain for 30 seconds. The sample was then reweighed to obtain the end weight (W 2 ). The fabric absorbency is given by W 2 ⁇ W 1 /W 1 .
  • Cellulose ethyl sulfonate fabric prepared in accordance with the present invention containing 10% by weight 1.7 decitex 40 mm staple bicomponent fiber (ES-CURETM manufactured by Fiber Visions) was manufactured in a similar manner to Example 9, except the thermal bonding step was conducted at 135° C., due to the higher melting sheath component.
  • a fabric containing 10% 4.0 decitex ES-LOW MELTTM was also produced as in Example 9. The following table shows the results:
  • TENCEL® fibers were incorporated at a level of 20% by weight into cellulose ethyl sulfonate nonwoven materials and found that wet strength is improved significantly, while absorbency is little compromised.
  • Cellulose ethyl sulfonate fiber in accordance with the present invention was cut to 50 mm staple and blended in a 20% by weight proportion with 1.4 decitex 50 mm staple TENCEL® fiber (manufactured by Lenzing AG) through a sample card. The resulting web was needlebonded.
  • the following table shows the results:
  • This example describes a blend of silver alginate fibers with cellulose ethyl sulfonate fibers using the techniques as generally set forth in WO 02/24240, which is incorporated by reference.
  • Calcium alginate fibers containing approximately 24% by weight silver were manufactured by immersing calcium alginate fibers in a mixture of water/acetone/silver nitrate, followed by washing in acetone/water and finally acetone before drying the fibers at 50° C. These fibers were cut to 50 mm staple and blended with cellulose ethyl sulfonate staple fibers in such a ratio to give approximately 1.5% silver on weight of dressing, then the blend carded and needle-bonded to give approximately 100 gsm needled fabric. The fabric had an off-white color on prolonged exposure to light.
  • the dressing was found to be antimicrobial, i.e., inhibited formation of greater than 99.9% of daughter cells (methicillin resistant Staphylococcus aureus ).
  • a PHMB-loaded cellulose ethyl sulfonate fabric was produced by the spray method using a 20% aqueous solution of PHMB to give 0.6% PHMB by weight on dressing.
  • a sample of the dressing was subjected to the “milk test.” The dressing remained antimicrobial for 72 hours, while the control sample became populated with microbes after 24 hours.
  • Cellulose ethylsulphonate fibers with a fiber absorbency of 4.7 g/g as measured by the method in Example 1 were cut to 50 mm staple, then carded and needled to give a fabric.
  • the absorbency of this fabric was measured by weighing a 5 cm ⁇ 5 cm square of sample material (W 1 ).
  • W 1 sample material
  • Solution A sodium/calcium solution
  • the square was lifted out of the petri-dish by holding the square by one corner, and the sample was allowed to drain for 30 seconds, then the sample was reweighed (W 2 ).
  • the fabric absorbency is given by W 2 ⁇ W 1 /W 1 .
  • the wet strength was measured by cutting test specimens 2.5 cm wide ⁇ 10 cm long from the fabric.
  • the sample was mounted in an Instron 3343 tensile testing machine to give a gauge length 5 cm.
  • the sample was then wetted with 2.5 ml of solution A (sodium/calcium solution), left for one minute, and then tested at 100 mm/min.
  • the absorbency and tensile strength results are shown in the table below:

Abstract

This invention relates to absorbent materials useful in the manufacture of absorbent articles, in particular dressings for the advanced wound care market. The absorbent materials of the present invention are sulfonated polysaccharides, particularly water-insoluble cellulose alkyl sulfonates in which the cellulose is substituted by one type of alkyl sulfonate group. The invention also provides a process for the manufacture of such materials. The preferred cellulose alkyl sulfonate described herein is cellulose ethyl sulfonate. Reinforcing fibers and/or antimicrobial agents are optionally applied to the cellulose alkyl sulfonate.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application claims priority to and is a Continuation of U.S. patent application Ser. No. 12/574,322, filed on Oct. 6, 2009, which claims priority to United Kingdom Patent Application, GB 0821675.6, filed on Nov. 27, 2008, and European Patent Application, 08171355.4, filed on Dec. 11, 2008, each of which are incorporated herein by reference in their entirety.
  • STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
  • Not applicable.
  • BACKGROUND OF THE INVENTION
  • Absorbent fibers useful as components in advanced wound care dressings are known in the art, particularly fibers based on alginic acid, carboxymethylcellulose, and carboxymethylchitosan, and salts thereof.
  • Dressings based on fibers of alginic acid or its salts have good overall absorbency of wound fluid, but suffer from slow absorption due to the need to exchange multivalent ions binding the fibrous structure together with sodium ions present in wound fluid. Although this ion exchange renders the fibers swellable in ion containing aqueous media, allowing significant absorption of fluid, the mechanical strength of the gelled fibers is compromised, and it is not routinely possible to remove a saturated dressing in one piece. Frequently, the dressing must be irrigated with saline to wash it away, and this can be traumatic for the patient.
  • Carboxymethyl cellulose fibers have also been used as the main component in advanced wound care dressings, and these too have significant absorptive capacity for wound fluid. Their advantage over alginate-type dressings is that absorption of fluid is virtually instantaneous since no ionic exchange is required to render the fibers gellable. In addition, those fibers based on a highly crystalline cellulose, such as lyocell, and in particular those described in EP0616650 and EP0680344, tend to retain a higher level of mechanical strength and therefore may be removed from the wound site in one piece. However the absorptive capacity of this class of material is strongly dependent on the pH of the wound fluid, reducing dramatically at acidic pH. This is a serious drawback since chronic wound fluid pH can range between 4 and 8 depending on the state of healing. Furthermore, it has been recognized that artificially lowering the pH of the wound environment may lead to improved healing outcomes. For instance, it has been found (Tsioras et al, article presented at 19th Annual Symposium on Advanced Wound Care, San Antonio, Tex., Apr. 30, 2006-May 3, 2006) that applying a wound dressing containing a pH adjusting cream of pH 2.8 decreased the time it took for the wound to close. In another study, burn wounds healed quicker when treated with fluid having a pH of 3.5 (Kaufman et al., Burns Incl Therm Inj, 12(2) 84-90 (1985)). Indeed, preparations are commercially available for use in conjunction with absorbent dressings to reduce the pH of the wound environment. For instance, CADESORB® available from Smith & Nephew has a pH of about 4.35.
  • It is desirable for an absorbent dressing to perform well at acidic pH, and preferably for it to perform well over a wide range of pH. Since absorbent dressings based on carboxymethylcellulose do not perform well in low pH environments, there is a need for an instantly gelling, absorptive dressing that continues to absorb to a good level at reduced pH.
  • It is desirable for absorbent fibers for use in absorbent dressings to be obtained from a renewable resource, to be inexpensive and also biodegradable. Hence, there is considerable interest in cellulose as a renewable and biodegradable source of absorbent material. U.S. southern pine fluff pulp is used as an absorbent material in the personal care industry. However, it is commonly used in conjunction with other absorbent materials, and commonly materials that are not renewable and biodegradable, for example acrylic acid polymers. The reason for this is that absorbed liquid is not effectively retained in materials that are made exclusively of cellulosic fibers.
  • The cellulose fiber can be modified by sulfonation, for example by substitution with an alkyl sulfonate at one or more of the hydroxyl groups on the anhydroglucose monomers that make up the cellulose backbone, forming ether linkages. Cellulose derivatives of this type are known as cellulose sulfonates or cellulose alkyl sulfonates.
  • Commercially available cellulose ethers are, as a rule, water-soluble compounds. In particular, cellulose ethyl sulfonate is known to be water-soluble.
  • Herzog et al., U.S. Pat. No. 4,990,609 describes cellulose ethyl sulfonates of high solution quality, which are prepared by addition to cellulose of an alkylating agent and subsequently addition of alkali. The process is compared to the two-stage process for the production of cellulose ethyl sulfonate described in SU757540.
  • Cellulose ether sulfonates have been modified further in order to produce water insoluble products. For instance Glasser et al., U.S. Published Patent Application No. 2006/0142560 refers to absorbent fibers based on mixed cellulose alkylsulfonates in which the cellulose is substituted by two different groups, an alkyl sulfonate and a hydroxyalkyl sulfonate, specifically ethyl sulfonate and 2-hydroxypropyl sulfonate. Water insolubility of the modified cellulose is believed to result from the presence of the 2-hydroxypropyl sulfonate group.
  • Shet et al., U.S. Pat. No. 5,703,225 refers to a water-insoluble sulfonated cellulose that is a hydroxy sulfonic cellulose in which both the sulfur atom of a sulfonic group and a hydroxyl group are directly attached to a carbon atom on the cellulose chain.
  • To be suitable for use in wound dressings, absorbent materials must retain their integrity and hence be water-insoluble. The principal disadvantage of the water insoluble cellulose alkyl sulfonates that have been developed for use as absorbent materials to date is the requirement for substitution of the cellulose with at least two different groups. Compared to substitution with a single substituent, additional reactants and additional processing steps are not desirable, and are likely to increase the cost of manufacture. Furthermore, as the cellulose is increasingly modified, benefits associated with the natural fiber, such as its biodegradability, may be impaired.
  • SUMMARY OF THE INVENTION
  • It has surprisingly been found that water-insoluble cellulose alkyl sulfonates may be prepared by the substitution of cellulose with only one type of alkyl sulfonate.
  • It will be clear to those skilled in the art that other polysaccharide substrates could be converted to an alkyl sulfonate derivative in accordance with the invention. For example, chitin and chitosan are natural polysaccharides based on D-glucosamine units, which have hydroxyl groups at positions at C3 and C5 where reaction substitution with alkyl sulfonate groups can take place. In addition, it is possible to substitute at the amine group in the C2 position, attaching the alkyl sulfonate via the nitrogen.
  • Thus, according to a first aspect of the invention, there is provided an absorbent article comprising as an absorbent material, a water-insoluble polysaccharide alkyl sulfonate, wherein the polysaccharide is substituted with one type of alkyl sulfonate.
  • The modified polysaccharides of the invention are highly advantageous for use as absorbent materials in wound dressings because they exhibit excellent absorption and retention of fluid while maintaining their integrity sufficiently to be removed from the wound site in one piece, without irrigation, and with minimum pain and shedding. As with carboxymethyl cellulose, absorption of fluid is virtually instantaneous since ionic exchange is not required for the fibers to become gellable. However, the water-soluble polysaccharide alkyl sulfonates of the present invention are advantageous compared to carboxymethyl cellulose because the absorptive capacity may be affected to a lesser extent by changes in pH. Wound dressings containing these materials may continue to absorb to a good level at low pH.
  • The polysaccharide alkyl sulfonate may be used in the form of fibers.
  • The polysaccharide alkyl sulfonate may be a cellulose alkyl sulfonate, and the following description refers primarily to such embodiments of the invention. It will be appreciated, however, that other polysaccharides may be utilized.
  • The alkyl moiety of the alkyl sulfonate substituent group is preferably a lower alkyl having 1 to 6 carbon atoms, preferably methyl, ethyl, propyl, or butyl. The alkyl moiety may be branched or unbranched, and hence suitable propyl sulfonate substituents may be 1- or 2-methyl-ethylsulfonate. Butyl sulfonate substituents may be 2-ethyl-ethylsulfonate, 2,2-dimethyl-ethylsulfonate, or 1,2-dimethyl-ethylsulfonate. The alkyl sulfonate substituent group that is most preferred is ethyl sulfonate.
  • Thus, a preferred cellulose alkyl sulfonate of the present invention is cellulose ethyl sulfonate, where ethyl sulfonate or one of its salts is attached via one or more of the hydroxyl groups on the anhydroglucose units of the cellulose. The structure of one anhydroglucose unit substituted by one ethyl sulfonate group is depicted by formula (I)
  • Figure US20160114074A1-20160428-C00001
  • Formula (I) is not meant to depict the exact chemical structure of cellulose ethyl sulfonate prepared in accordance with the invention, because substitution can take place at any of the hydroxyl positions in the cellulose macromolecule, in any distribution up to the maximum degree of substitution that is possible.
  • The average degree of substitution refers to the mean number of hydroxyl positions substituted with an alkyl sulfonate substituent group, or put another way, the mean number of moles of alkyl sulfonate groups per mole of anhydroglucose unit in the cellulose polymer. The maximum degree of substitution is therefore 3, when the anhydroglucose unit is substituted at all three hydroxyl positions. The degree of substitution when an average of one hydroxyl group is substituted per anhydroglucose unit, as shown in Formula (I), is 1.
  • Cellulose ethyl sulfonate is described in the prior art as a water-soluble compound, and is modified further to render it water-insoluble, e.g., by alkylation with 3-chloro-2 hydroxypropyl sulfonate. Water insoluble cellulose ethyl sulfonate and other insoluble cellulose alkyl sulfonates wherein the cellulose is substituted with one type of alkyl sulfonate are therefore believed to be novel.
  • Thus, in another aspect of the invention, there is provided a water-insoluble cellulose alkyl sulfonate, wherein the cellulose is substituted with one type of alkyl sulfonate.
  • The functional properties of the cellulose alkyl sulfonates of the present invention depend on the degree of substitution, the chain length of the cellulose backbone structure, and the structure of the alkyl sulfonate substituent. Solubility and absorbency are largely dependent on the degree of substitution: as the degree of substitution is increased, the cellulose alkyl sulfonate becomes increasingly soluble. It follows that, as solubility increases, absorbency increases.
  • To be useful in an absorbent advanced wound dressing, the fibers of the absorbent material preferably have an absorbency of at least 8 grams per gram (g/g) of 0.9% saline solution, as measured by the method described below in Example 1. The fibers of the preferred cellulose alkyl sulfonates of the present invention have an absorbency (of 0.9% saline solution) of at least 8 g/g, more preferably at least 9 g/g, most preferably at least 10 g/g.
  • Another class of woundcare dressings, those which simply provide a non-adhesive wound contact layer, sometimes known as Tulle, do not require such a high level of absorbency since they may be used on wounds that exhibit a lower level of wound exudate generation, or a more absorbent layer is used on the top surface of the contact layer. However the key attribute of such contact layers is that they do not adhere to the wound bed. A fabric material comprising cellulose alkyl sulfonate fibers with a fabric absorbency greater than 2 g/g provides for a good contact layer dressing as the fibers absorb sufficient exudate, thus forming a gelled material to provide a non-adhesive surface. Thus, in another aspect, cellulose alkyl sulfonates of the present invention have an absorbency (of 0.9% saline solution) of greater than 2 g/g, 4 g/g, or 6 g/g.
  • It has been found that the average degree of substitution should preferably be less than 0.4 for the cellulose alkyl sulfonate to be substantially water-insoluble. By “substantially” is meant in this context that when the cellulose alkyl sulfonate is exposed to an excess of an aqueous medium it does not dissolve into solution, or at least that dissolution is so low as to have no significant effect on the properties of the polymer.
  • The average degree of substitution is preferably less than 0.4, more preferably less than 0.3. In some preferred embodiments of the invention, the average degree of substitution of the cellulose alkyl sulfonate is from about 0.05 to about 0.4, more preferably from about 0.1 to about 0.3.
  • Cellulose alkyl sulfonates with alkyl group having 2 to 6 carbon atoms according to the present invention can be formed by reaction of cellulose with an alkenyl sulfonate or one of its salts in the presence of a base, preferably an alkali metal hydroxide, either in aqueous or non-aqueous medium. Cellulose alkyl sulfonate with 1 carbon atom, i.e., cellulose methylsulfonate, can be formed by reaction with chloromethane sulfonic acid or one of its salts in the presence of a base, preferably an alkali metal hydroxide, either in aqueous or non-aqueous medium.
  • Alkalization and alkyl sulfonation (which in this case is an etherification step) may be carried out as a single step in which the base and alkenyl sulfonate or chloromethylsulfonate are added at the same time in one reaction vessel (a “one-pot” process). Alternatively, alkalization and alkyl sulfonation may be carried out in two separate reaction steps, treating the cellulose first with alkali and then alkyl sulfonating agent, or with alkyl sulfonating agent and then alkali.
  • One-pot processes are often desirable because they can be easier, quicker, and by minimizing the number of reaction steps a higher yield may be obtained.
  • When the alkali and alkyl sulfonating agent are used simultaneously in a one-pot process, to produce a cellulose alkyl sulfonate of the present invention, the reaction rate is higher than that observed for the equivalent reaction in which alkalization and alkyl sulfonation are carried out in separate steps. As mentioned above, the greater the degree of substitution, the greater the absorbency of the cellulose alkyl sulfonate material. Thus, the reaction rate may be determined by measuring the time taken for the alkyl sulfonation reaction to yield a product having a particular degree of absorbency. In practice, it is not easy to stop a reaction at a specific absorbency level. Nevertheless, it is clear that a reaction taking 90 minutes to reach an absorbency of 14.2 g/g is significantly faster than one that takes 120 minutes to reach an absorbency of only 9.7 g/g.
  • The amount of water in the reaction mixture is also shown to affect the reaction rate. Lowering the water content in a reaction in which alkalization and alkyl sulfonation are carried out simultaneously results in a significant increase in reaction rate. Lowering the water content in the alkyl sulfonation step of a reaction in which alkalization and alkyl sulfonation are carried out separately increases the rate, but to a lesser extent.
  • A one-pot process would also be expected to minimize exposure of the cellulose to the base, therefore keeping the alkaline, oxidative degeneration of the cellulose to a minimum. It is necessary to minimize degeneration of the cellulose during processing in order to ensure that the modified cellulose is sufficiently strong to be useful as an absorbent material in a wound dressing, and indeed to maximize both the dry strength and the wet strength of the product.
  • However, it has been found that the strength of the fibers prepared by a one-pot process may be surprisingly and significantly weaker than fibers prepared by carrying out alkalization and alkyl sulfonation in separate steps, depending on the level of water used in the reaction mixture.
  • When higher levels of water are used in the reaction, the cellulose alkyl sulfonates produced by a one-pot process have a surprisingly low fiber strength compared to the cellulose alkyl sulfonates produced by the analogous two-step process. The fibers are too weak to be suitable for processing using normal non-woven textile processing methods. If the level of water used in the reaction is reduced, the reaction rate increases and also the fiber strength increases to a useable level.
  • According to a further aspect of the invention, there is provided a process for the preparation of water-insoluble cellulose alkyl sulfonate comprising the simultaneous reaction of cellulose with an alkali and alkyl sulfonating agent, and wherein the weight of water present in the reaction is less than 1030%, preferably less than 1015%, preferably less than 950%, of the (dry) weight of the cellulose. Fiber absorbencies average about 15 g/g at 1027% water on a dry weight basis.
  • According to a further aspect of the invention, there is provided a process for the preparation of a water-insoluble cellulose alkyl sulfonate, which process comprises the separate steps of:
  • (a) treating the cellulose with alkali;
  • (b) reacting the product of step (a) with an alkenyl sulfonate or its salt, or chloromethane sulfonic acid or its salt; and
  • (c) isolating the product of step (b).
  • This two-step process is surprisingly beneficial when the level of water used in step (b) is more than 950% of the (dry) weight of the cellulose.
  • In another aspect of the present invention, an absorbent article comprising the cellulose alkyl sulfonate fibers is provided. When fully hydrated, the absorbent article is substantially transparent. This is advantageous in wound care applications since the state of the underlying wound can be determined without removing the dressing.
  • In another aspect, the present invention is directed to an absorbent fabric article comprising cellulose alkyl sulfonate of the present invention which is reinforced with a reinforcing fiber blended or bonded to the water-insoluble polysaccharide alkyl sulfonate. The use of sheath/core bicomponent fibers is particularly advantageous because the sheath material melts at a lower temperature than the core so on bonding leaves a strong, unmelted core superstructure. In the present invention, it was found unexpectedly that when thermoplastic bicomponent fibers based on polyolefins (preferably a polypropylene core/polyethylene sheath) are used to reinforce cellulose ethyl sulfonate fibers, even up to a level of 20% by weight, the absorbency of the resultant fabric is not compromised by the substantially non-absorbent, hydrophobic reinforcing component. Moreover, using a reinforcing fiber having a lower linear density allows for a reduction in the weight amount of the fibers, resulting in increased transparency of the absorbent article.
  • In yet another aspect, the absorbent fabric articles comprising the cellulose alkyl sulfonate of the present invention exhibit an absorbency of at least 15 g/g using a sodium/calcium test solution. Absorbency is preferably not compromised using a reinforcing fiber, while wet strength is improved. Thus, the absorbency of the composite product comprising the cellulose alkyl sulfonate fibers and the reinforcing fibers is preferably at least 15, 16, 17, 18, 19, or 20 g/g using the sodium/calcium test solution. The wet strength of the composite product is preferably at least 1, 2, 3, 4, 5, or 6 N/cm when using a sodium calcium test solution and Instron tensile testing machine as provided herein.
  • In still another aspect, one or more antimicrobial agents are applied to the polysaccharide alkyl sulfonate fibers and absorbent articles of the present invention. Preferred agents include silver and/or polyhexamethylene biguanide (“PHMB”). The weight of the silver cation in the product is preferably about 0.5 to 5 wt %, preferably about 1 to 3 wt %, and still more preferably about 1.5 to 2.0 wt %. The weight of PHMB is preferably about 0.1 to 1%, and is preferably about 0.5 to 0.7 wt %.
  • Additional aspects of the invention, together with the advantages and novel features appurtenant thereto, will be set forth in part in the description which follows, and in part will become apparent to those skilled in the art upon examination of the following, or may be learned from the practice of the invention. The objects and advantages of the invention may be realized and attained by means of the instrumentalities and combinations particularly pointed out in the appended claims.
  • DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows the absorbency of cellulose ethyl sulfonate (“CES”) fibers of the present invention comparable to carboxymethyl cellulose (“MC”) fibers as described in Example 8.
  • DETAILED DESCRIPTION OF THE INVENTION
  • Processes for preparing the cellulose alkyl sulfonates of the present invention were compared using 47% NaOH solution, 25% sodium vinylsulfonate solution, and different quantities of water in the alkyl sulfonation reaction. The properties of the fibers are presented in Table 1 below:
  • TABLE 1
    Summary of Cellulose Ethyl Sulfonate
    Time of Weight water in Weight of NaOH in
    alkylsulfonation alkylsulfonation alkylsulfonation Absorbency Filament
    Reaction type (min) (% of fiber wt) (% fiber wt) (g/g) strength
    Two-step high water 120 970 197 9.7 OK
    (SFM006/69)
    Two-step low water 120 460 177 13.7 OK
    (SFM006/136)
    One-pot high water 90 960 198 14.2 Low
    (SFM006/148c)
    One-pot low water 70 630 198 11.9 OK
    (SFM006/145a)
  • Comparable amounts of water were used in the two-step high water reaction and the one-pot high water reaction. The reaction rate of the one-pot process was significantly higher, but the filament strength of the cellulose ethyl sulfonate product produced by the one-pot process was lower than the strength of the fiber produced by the two-step process with separate alkalization and alkyl sulfonation steps. Indeed, the filament strength of the product of the one-pot process was too low for the material to be effective for use, as intended, in wound dressing applications.
  • In the one-pot process for the preparation of water-insoluble cellulose alkyl sulfonate comprising the simultaneous reaction of cellulose with an alkali and alkyl sulfonating agent, the weight of water present in the reaction is less than 1050% of the (dry) weight of the cellulose, more preferably less than 950% of the weight of the cellulose, still more preferably less than 800% of the weight of the cellulose, more preferably less than 700% by weight of the cellulose, and most preferably less than 650% by weight of the cellulose.
  • Reducing the level of water in the second alkyl sulfonation step in the two-step process is shown to increase the reaction rate. However, it is not always practicable to carry out that reaction step using lower levels of water, as it becomes increasingly difficult to wet the cellulose as the volume of alkyl sulfonate reactant decreases. In any case, when using lower levels of water in the reaction, the one-pot process is preferred.
  • At higher levels of water, the two-step process is most suitable for producing cellulose alkyl sulfonates of the present invention with adequate fiber strength. Preferably, the weight of water present in the alkyl sulfonation step is more than 650% by (dry) weight of the cellulose, more preferably more than 750% by weight of the cellulose, more preferably more than 850% by weight of the cellulose, and most preferably more than 950% by weight of the cellulose.
  • To be suitable for use in the present invention, the cellulose is preferably fibrous in nature. The cellulose fibers should have a high degree of crystallinity and total orientation in order that the fibers maintain sufficient strength after derivatization to be processed, and that the resulting material is strong enough for its intended use.
  • In particular, the use of alkali in the alkalization step can degrade the cellulose backbone, causing chain scission and a reduction in the degree of polymerization, thereby resulting in the fibers having a lower strength after derivatization. The dry strength of the derivatized fibers must be sufficient to enable processing into woven or nonwoven structures, and, to be useful as an absorbent material in a wound dressing, the wet strength of the material must be sufficient to allow removal from the site in one piece.
  • Fibrous celluloses with a high degree of crystallinity, that are particularly suitable for use in the invention, include cotton or regenerated cellulose fibers such as lyocell.
  • It will be clear to those skilled in the art that it is possible to sulfonate particulate cellulose such as pulp fibers, then dissolve the sulfonated cellulose in a suitable solvent, such as a lyocell solvent or an ionic liquid, and spin the sulfonated cellulose as fibers, or extrude the sulfonated cellulose as a film or other extrusion to produce the absorbent material of the invention. Furthermore, a blowing agent could be added to the solution in order to produce a foamed absorbent material.
  • The cellulose may be alkalized by treatment with a strong alkali, preferably an alkali metal hydroxide such as sodium hydroxide. A 47% sodium hydroxide solution has been found to be suitable. Generally, the higher the concentration of alkali and the higher the reaction temperature, the faster the rate of reaction. The strength of the reaction conditions should be balanced with the need to avoid degradation of the cellulose substrate. However, the level of degradation of the cellulose is considerably lower than might be expected under the relatively intense reaction conditions that are required for alkalization. When carrying out the two-step process, it may be beneficial to remove excess alkali before proceeding with second alkyl sulfonation step, e.g., by mechanically squeezing the alkalized fibers.
  • In the case of the alkyl sulfonation step (or etherification step) with 2 to 6 carbon atoms, the reaction involves the nucleophilic addition of the alkoxide ion to an alkenyl sulfonate, specifically α-alkenyl sulfonate or its salt. The α-alkenyl sulfonate is preferably a lower alkenyl sulfonate, in which the alkenyl moiety has 2 to 6 carbon atoms. Preferably the α-alkenyl sulfonate is vinyl sulfonate, allyl sulfonate (1-propenyl sulfonate), isopropenyl sulfonate (1-methylvinyl sulfonate), 1-butenyl sulfonate, 1-methyl allyl sulfonate (1-methyl-1-propenyl sulfonate) or 2 methylallyl sulfonate (2-methyl-1-propenyl sulfonate). In a particularly preferred embodiment, the α-alkenyl sulfonate is vinyl sulfonate, more preferably the sodium salt of vinyl sulfonate, and hence the cellulose alkyl sulfonate product is cellulose ethyl sulfonate.
  • The sodium salt of vinyl sulfonate is commercially available as an approximately 30% aqueous solution. It may be brought into contact with the cellulose or alkalized cellulose by methods known in the art, for instance spraying onto the cellulose, or mixing using stirrers. The conversion to cellulose alkyl sulfonate can take place at any temperature up to the boiling point of the reaction mixture, or beyond it if a pressurized system is used. The rate of reaction is increased if the reaction stage is carried out at elevated temperature. The preferred range is 30-95° C. to give a useful degree of substitution in an economic time. Further, fresh charges of reactant can be introduced at any time throughout the reaction. The degree of substitution can be controlled by control of reaction temperature and, in particular, by control of the reaction time.
  • Vinyl sulfonate is thought to be less hazardous than some of the halogenated reactants, particularly chlorinated reactants, which are typically used to prepare the absorbent materials currently available for use in wound care products. Certainly, chloroacetic acid, used in the manufacture of carboxymethyl cellulose, is a potentially dangerous alkylating agent. Its use during the manufacturing process is undesirable, and retention of any residual chloroacetic acid in the absorbent product may be harmful, at the least causing skin irritation. The use of only one type of alkyl sulfonate also presents potential advantages in terms of safety and removal of residual reactant compared to other water-insoluble cellulose alkyl sulfonates that are known, in which the cellulose is substituted with more than one type of alkyl sulfonate, if only because of the relative simplicity of the chemistry.
  • After the reaction has proceeded to the desired extent, the reaction can be stopped by neutralizing the reaction mixture, i.e., reducing the pH to approximately neutral by addition of acid. The acid may be any common mineral or organic acid such as hydrochloric or acetic acid, respectively. The cellulose alkyl sulfonate product can then be washed free of by-products and impurities by employing washing stages known in the art. Such stages include washing with water, organic liquids, or mixtures thereof. Particularly useful are mixtures of a lower alcohol and water. Washing efficiency can be enhanced by washing at elevated temperature. After washing, it may be desirable to apply a processing aid, such as glycerol, as is common practice in the production of, for example, cellulose film (cellophane). This can be achieved by methods known in the art, such as dipping, spraying etc.
  • Finally the derivatized cellulose article should be dried to remove residual liquid from the previous stages. Drying can be carried out by methods known in the art such as forced air drying, radiant heat drying etc.
  • The absorbent materials of the present invention exhibit instant gelling in aqueous media, good absorbency and, crucially, good retention of absorbency in an acidic environment. This renders them ideal for use as an absorbent wound dressing, or as part of an absorbent dressing. They are particularly useful for wounds with moderate to high levels of exudates, and for flat or cavity wounds of this type. Typical examples include pressure sores and leg ulcers.
  • The use of the absorbent materials of the present invention is not limited to wound care products, and they are expected to be useful for many other applications. Their absorbent properties, biodegradability, and the fact that cellulose is a renewable material, mean that the cellulose alkyl sulfonates of the invention are also particularly desirable for use in the personal care sector, particularly for disposable sanitary articles such as nappies (diapers), disposable nappies and training pants, feminine care products, e.g., tampons, sanitary towels, or napkins and pant liners, and incontinence products. The simplicity of the chemistry and the availability of the reactants enable the cost of manufacture of such articles to be kept advantageously low.
  • Other medical products are envisaged, for example, surgical and dental sponges. The materials could also be useful in packaging, for example as absorbent pads in food containers.
  • The cellulose alkyl sulfonates of the present invention may be processed according to known methods into a wide variety of forms, depending on their intended use. The manner in which the derivative cellulose is processed has a significant effect on the properties of the final product, particularly the strength, gelling time, and absorbency. Preferred cellulose alkyl sulfonate products for use in wound care articles are carded, needle-bonded nonwovens.
  • The cellulose alkyl sulfonates may be combined with one or more reinforcing fibers as generally set forth in Hansen, U.S. Pat. No. 5,981,410 titled “Cellulose-Binding Fibres”; Stengaard et al., U.S. Pat. No. 6,811,716 titled “Polyolefin Fibers and Method for the Production Thereof”, Jensen et al., U.S. Pat. No. 5,958,806 titled “Cardable Hydrophobic Polyolefin Fibres Comprising Cationic Spin Finishes;” all of which are incorporated by reference. Preferred reinforcing fibers are thermoplastic biocomponent fibers, most preferably having a polyolefin component. Thus, the fibers preferably comprise a polyolefin-containing polymeric material of which the largest part (by weight) consists of homo- or copolymers of monoolefins such as ethylene, propylene, 1-butene, 4-methyl-1-pentene, etc. Examples of such polymers are isotactic or syndiotactic polypropylene, polyethylenes of different densities, such as high density polyethylene, low density polyethylene, and linear low density polyethylene and blends of the same. The polymeric material may be mixed with other non-polyolefin polymers such as polyamide or polyester, provided that polyolefins still constitute the largest part of the composition. The melts used to produce the polyolefin-containing fibers may also contain various conventional fiber additives, such as calcium stearate, antioxidants, process stabilizers, compatibilizers, and pigments. Methods for applying the thermoplastic biocomponent fibers are described in EP0740554; EP0171806; Ejima et al., U.S. Pat. No. 5,456,982; Davies, U.S. Pat. No. 4,189,338; Davies, U.S. Pat. No. 3,511,747; and Reitboeck et al., U.S. Pat. No. 3,597,731, which are incorporated by reference.
  • The thermoplastic bicomponent fibers may be of the sheath-core type with the core being located either eccentrically (off-center) or concentrically (substantially in the center), or of the side-by-side type, in which each of the two components typically has a semi-circle cross section. Bicomponent fibers having irregular fiber profiles are also contemplated, e.g., an oval, ellipse, delta, star, multilobal, or other irregular cross section, as well as splittable fibers. The bicomponent fibers will typically have a high melting and low melting polyolefin component which comprise, respectively, polypropylene/polyethylene (the polyethylene comprising HDPE, LDPE, and/or LLDPE), high density polyethylene/linear low density polyethylene, polypropylene random copolymer/polyethylene, or polypropylene/polypropylene random copolymer. Preferred thermoplastic biocomponent fibers are commercially available from Fiber Visions (Athens, Ga.). Suitable thermoplastic biocomponent fibers comprise 30, 25, 20, 18, 16, 14, 12, 10, 8, 6, or 4 wt % or any range there between of the composite absorbent article. The thermoplastic biocomponent fibers preferably have a linear density of about 1.7, 1.9, 2.1, 2.3, 2.4, 2.6, 2.8, 3.0, 3.2, 3.4, 3.8, 4.0, 4.2, 4.4, 4.6, 4.8, 5.0 decitex up to 16.7 decitex or any range therebetween. However, it has been surprisingly discovered that when high-density fibers (e.g., 4.0 decitex) are incorporated into the absorbent article comprising the cellulose alkyl sulfonate at high levels (e.g., about 20%), the absorbency of the article is not compromised. Moreover, using a reinforcing fiber having a lower linear density allows for a reduction in the weight amount of the fibers, resulting in increased transparency. Thus, in one aspect, the thermoplastic biocomponent fibers preferably comprise about 10 to 30 wt % (more preferably about 10 to 20%, and still more preferably about 10 to 13%) of the absorbent article and have a linear density of about 1.7 to 4.0 decitex (more preferably about 1.7 to 1.9 decitex). The temperature used to fuse the fibers together is typically in the range of 90 to 162° C., preferably about 120 to 125° C.
  • In another aspect, the reinforcing fibers comprise lyocell fibers. These fibers generally comprise a cellulose obtained by an organic solvent spinning process. Preferably, the lyocell fiber is generated from cellulose fibers using various amine oxides as solvents. In particular, N-methylmorpholine-N-oxide (“NMNO”) with water (about 12%) proves to be a particularly useful solvent. Examples of processes for preparing lyocell fibers are described in McCorsley et al., U.S. Pat. Nos. 4,142,913; 4,144,080; 4,211,574; 4,246,221; and 4,416,698, and others. Jurkovic et al., U.S. Pat. No. 5,252,284 and Michels et al., U.S. Pat. No. 5,417,909 deal especially with the geometry of extrusion nozzles for spinning cellulose dissolved in NMMO. Brandner et al., U.S. Pat. No. 4,426,228, is exemplary of a considerable number of patents that disclose the use of various compounds to act as stabilizers in order to prevent cellulose and/or solvent degradation in the heated NMMO solution. Franks et al., U.S. Pat. Nos. 4,145,532 and 4,196,282, deal with the difficulties of dissolving cellulose in amine oxide solvents and of achieving higher concentrations of cellulose. All of these patents are incorporated herein by reference. One lyocell product produced by Lenzing is presently commercially available as TENCEL® fiber. The methods for including these cellulose fibers into nonwoven structures to aid in integrity of the product is well known, see, e.g., GB1207352, which is incorporated by reference. In one aspect, the lyocell fibers comprise 26, 24, 22, 20, 18, 16, 14, 12, 10, 8, 6, or 4 wt % or any range therebetween of the composite absorbent article. The lyocell fibers preferably have a linear density of about 0.7, 0.9, 1.1, 1.3, 1.5, 1.7, 1.9, 2.1, 2.3, 2.4, 2.6, 2.8, 3.0, 3.2, 3.4, 3.8, 4.0, 4.2, 4.4, 4.6, 4.8, 5.0, 10, 15, 20, 25, up to 30 decitex or any range therebetween. As shown in the examples below, it has been surprisingly discovered that when low density fibers (e.g., about 1.2 to 1.6 decitex) are incorporated into the composite absorbent article at high levels (e.g., about 10 to 30 wt %, preferably about 10 to 20 wt %), the wet strength is improved while absorbency is not compromised.
  • In still another aspect, one or more antimicrobial agents are applied to the cellulose alkyl sulfonate of the present invention. Preferred agents include silver and/or polyhexamethylene biguanide (“PHMB”).
  • The present invention is also directed to a novel method for applying a metal ion to a hydrophilic, amphoteric, or anionic polymer, especially those used in a medical device, a wound dressing, or an ostomy device. Materials which are particularly adapted for the inventive method include gel-forming fibers such as AQUACEL® (WO 93/12275, WO 94/16746, WO 99/64079, and U.S. Pat. No. 5,731,083), or those described in WO 00/01425 or PCT/GB 01/03147; wound dressings containing similar gel-forming fibers behind or overlying a non-continuous or perforated skin-contact layer such as VERSIVA® (U.S. Pat. No. 5,681,579, WO 97/07758, and WO 00/41661); DUODERM® (U.S. Pat. No. 4,538,603), DuoDerm CGF™ (U.S. Pat. No. 4,551,490 and EP 92 999), or a blend of two or more fibers such as CARBOFLEX® (WO 95/19795). The present invention is well-suited for other materials which contain carboxymethylcellulose and the cellulose alkyl sulfonate of the present invention.
  • Polymers suitable for the present invention include, but are not limited to, polysaccharides or modified polysaccharides, polyvinylpyrrolidone, polyvinyl alcohols, polyvinyl ethers, polyurethanes, polyacrylates, polyacrylamides, collagen, gelatin, or mixtures thereof. In preferred embodiments, the polymers contain carboxymethylcellulose such as sodium carboxymethylcellulose. In one embodiment, the polymer can be a polysaccharide comprising a carboxymethylcellulose or alginate, or a mixture of carboxymethylcellulose and alginate. The coating step is most preferably used with the cellulose alkyl sulfonate of the present invention.
  • The invention will now be illustrated by the following non-limiting examples.
  • Example 1 Method for Determination of the Free Absorbency of Fibers
  • The fiber was cut into a 2-3 mm flock, and 0.5 g of cut fiber was placed in a 100 ml screw-top jar. 50 ml of test liquid (e.g., 0.9% saline, typically used to simulate the ionic strength of wound fluid) was added, and the jar shaken for 30 seconds to disperse the flock. The dispersion was then filtered through a 47 mm Buchner funnel fitted with a 42.5 mm diameter Whatman No. 4 filter paper, using a vacuum pump, with vacuum set to be greater than 0.8 bar for one minute. Then the fiber dispersion was removed and weighed. Fiber free absorbency was calculated using the following formula:
  • absorbency ( g / g ) = [ wet_dispersion _weight ( g ) dry_flock _weight ( g ) ] - 1
  • Example 2 Method for Determination of Breaking Tenacity and Elongation of Single Filaments
  • Tenacity and elongation at break of dry, single filaments was carried out using a tensile testing machine, fitted with appropriate jaws for gripping single filaments and load cell of the appropriate range.
  • The samples were conditioned for at least four hours and were tested in the standard atmosphere for testing textiles (20±2° C. and 65±2% relative humidity).
  • The machine was balanced and calibrated according to the manufacturer's instructions. Filaments were taken at random from different parts of the sample. The linear density of the filament was measured by an appropriate technique such the Vibraskop method. The filament was then placed between the jaws of the tensile testing machine and the test started. The following conditions were used:
      • Test length: 20 mm
      • Load range: 0-10 cN
      • Cross-head speed: 10 mm/minute
      • Chart speed (when applicable): 10-20 mm/minute
      • Number of tests: 10
  • After rupture, the crosshead was returned, and the broken ends of filament were checked and removed from the jaws. A note was made if the number of jaw breaks exceeded 10%.
  • The breaking load (cN) and the breaking extension (%) of each filament was usually printed out together with the statistics. In the case of individual breaking loads being printed out, individual tenacity results or a mean tenacity were calculated by hand, as follows:

  • mean tenacity (cN/tex)=mean breaking load in cN×10 mean linear density in dtex
  • Example 3 Preparation of Cellulose Ethyl Sulfonate Using a Two-Step Process
  • A 3 g sample of lyocell tow, known under the tradename TENCEL® (manufactured by Lenzing), was immersed in aqueous 47% sodium hydroxide for 25 minutes at 25° C. Excess sodium hydroxide was then removed by squeezing. Then 25 ml 30% sodium vinyl sulfonate solution (Fluka Chemicals) was added to the fiber and heated at 91° C. for 90 minutes. After this time the reaction mixture was neutralized to pH 7 by adding glacial acetic acid dropwise. Then the excess liquid was squeezed from the fiber, and the fiber was washed twice in a mixture of industrial methylated spirit (“IMS”) and water (80:20 v/v). After drying to constant weight at 60° C., the fiber was tested for absorbency.
  • Using the method outlined in Example 1, and an aqueous solution of 0.9% NaCl as the test liquid, an fiber free absorbency value of 11.1 g/g was achieved.
  • Example 4 Preparation of Cellulose Ethyl Sulfonate Using a Two-Step Process (SFM006/69)
  • A 2.5 g sample of TENCEL® fiber was immersed in 47% sodium hydroxide for 30 minutes at 20° C., after which excess liquid was removed by squeezing. 21 ml sodium vinyl sulfonate (30% aqueous solution) was poured over the fiber. The vessel containing fiber and reactant was then heated at 83° C. for two hours, after which time the sample was neutralized by the dropwise addition of glacial acetic acid until a pH of 7 was reached. The excess liquid was then squeezed from the fiber, and the fiber was washed twice with IMS/water (80:20 v/v), and finally in 100% IMS. After drying to constant weight at 60° C., the fiber was tested for absorbency according to the method in Example 1, using 0.9% aqueous NaCl as the test liquid. A fiber free absorbency value of 9.7 g/g was obtained.
  • Example 5 Preparation of Cellulose Ethyl Sulfonate Using a One-Pot Process with High Water Content
  • 3 g TENCEL® fiber was immersed in a mixture of 10 ml 47% NaOH and 25 ml 30% sodium vinylsulfonate solution, and heated for 75 minutes at 83° C. The reaction mixture was then neutralized by addition of acetic acid, after which the fiber was removed and washed in a mixture of IMS/water (80:20 v/v), and finally in 100% IMS. Drying was carried out at 60° C.
  • Using the method outlined in Example 1, and an aqueous solution of 0.9% NaCl as the absorbent test liquid, a fiber free absorbency value of 6.6 g/g was achieved. The fibers were visibly weaker than the fibers of Example 6, despite having a lower degree of substitution, as evidenced by the lower absorbency value.
  • Example 6 Preparation of Cellulose Ethyl Sulfonate Using a One-Pot Process with Low Water Content (SFM006/145a)
  • 3 g TENCEL® fiber was immersed in a mixture of 13 ml 30% sodium vinylsulfonate solution and 10 ml 47% NaOH solution, and heated for 70 minutes at 83° C. The reaction mixture was then neutralized by addition of acetic acid, after which the fiber was removed and washed in a mixture of IMS/water (80:20 v/v), and finally in 100% IMS. Drying was carried out at 60° C.
  • Using the method outlined in Example 1, and an aqueous solution of 0.9% NaCl as the test liquid, an fiber free absorbency value of 11.9 g/g was achieved.
  • Example 7 Comparative Absorbency Test for Underivatized Cellulose
  • TENCEL® fiber from the same batch used as the starting material for Examples 3 and 4 was subjected to the absorbency test outlined in Example 1, using 0.9% aqueous NaCl as the absorbent test liquid. A fiber free absorbency value of 0.9 g/g was obtained.
  • Example 8 Comparison of the Absorbency at Low pH of Cellulose Ethyl Sulfonate Fibers of the Present Invention with Carboxymethyl Cellulose Fibers of the Prior Art
  • The absorbency of carboxymethyl cellulose (CMC) fibers made according to the teachings in EP 0616650 was measured according to the method of Example 1 using 0.9% saline solution as absorbing liquid. The pH of the saline was then reduced successively by addition of 37% HCl and the absorbency measured again at each pH.
  • Cellulose ethyl sulfonate fibers were produced according to the present invention from lyocell fiber, and their absorbency measured in the same way at a range of pH values.
  • The results are shown graphically in FIG. 1. It is clear that cellulose ethyl sulfonate fiber of the invention retains significantly more of its absorbency at low pH where wound healing is believed to be enhanced.
  • Example 9 20% by Weight 4.0 Decitex Bicomponent Fiber-Reinforced Cellulose Ethyl Sulfonate Fabric
  • In this example, cellulose ethyl sulfonate fiber made according to the present invention to was cut to 50 mm staple and blended in a 20% by weight proportion with 4.0 decitex 40 mm staple bicomponent fiber (ES-LOWMELT™ manufactured by Fiber Visions) through a sample card. The resulting web was needlebonded, and then thermally bonded by heating in a recirculating oven set at 125° C. for 10 minutes. Comparative cellulose ethyl sulfonate fabric containing no reinforcing fiber was manufactured in a similar manner, without a thermal bonding step.
  • The wet strength was measured by cutting test specimens 2.5 cm wide×10 cm long from the fabric. The sample was mounted in an Instron 3343 tensile testing machine to give a gauge length 5 cm. The sample was then wetted with 2.5 ml of solution A (sodium/calcium solution), left for one minute, and then tested at 100 mm/min. The sodium/calcium Solution A is formed by dissolving 16.6 g of NaCl and 0.74 g of CaCl dihydrate in 2 L of water.
  • The clarity measured subjectively by placing beneath a gelled (0.9% saline hydrated) sample printed bold type face 12 pt Times New Roman and subjectively scoring the clarity from 0 (completely opaque, typeface not visible) to 10 (completely clear, undistorted typeface).
  • The absorbency was measured by weighing a 5 cm×5 cm square of sample material (W1). Next, the sample was placed in Solution A at 37° C. for 30 minutes in a petri-dish. Then the square was lifted out of the petri-dish by holding the square by one corner, and the sample was allowed to drain for 30 seconds. The sample was then reweighed to obtain the end weight (W2). The fabric absorbency is given by W2−W1/W1.
  • TABLE 2
    Summary of Test Results
    Fabric Wet
    Absorbency strength
    (g/g) (N/cm) Clarity
    CES Fabric 15.9 0.6 9
    20% 4.0 decitex bicomponent - 19.7 5.1 3
    reinforced fabric
  • Example 10 10% by Weight 1.7 Decitex Biocomponent Fiber-Reinforced Cellulose Ethyl Sulfonate Fabric
  • Cellulose ethyl sulfonate fabric prepared in accordance with the present invention containing 10% by weight 1.7 decitex 40 mm staple bicomponent fiber (ES-CURE™ manufactured by Fiber Visions) was manufactured in a similar manner to Example 9, except the thermal bonding step was conducted at 135° C., due to the higher melting sheath component. A fabric containing 10% 4.0 decitex ES-LOW MELT™ was also produced as in Example 9. The following table shows the results:
  • TABLE 3
    Test Results
    Wet
    strength
    (N/cm) Clarity
    10% 1.7 decitex bicomponent- 2.1 6
    reinforced fabric
    10% 4.0 decitex bicomponent- 0.6 6
    reinforced fabric
  • Example 11 20% by Weight 1.4 Decitex Lyocell-Reinforced Cellulose Ethyl Sulfonate Fabric
  • In this example, TENCEL® fibers were incorporated at a level of 20% by weight into cellulose ethyl sulfonate nonwoven materials and found that wet strength is improved significantly, while absorbency is little compromised. Cellulose ethyl sulfonate fiber in accordance with the present invention was cut to 50 mm staple and blended in a 20% by weight proportion with 1.4 decitex 50 mm staple TENCEL® fiber (manufactured by Lenzing AG) through a sample card. The resulting web was needlebonded. The following table shows the results:
  • TABLE 4
    Test Results
    Fabric
    Strength absorbency
    (N/cm) Clarity (g/g)
    Unreinforced cellulose 0.4 8 19.4
    ethyl sulfonate fabric
    TENCEL ® reinforced cellulose 3.3 5 18.8
    ethyl sulfonate fabric

    The strength, clarity, and absorbency of the fabric was determined as set forth in Example 9.
  • Example 12 Silver Alginate Fiber Blend Process
  • This example describes a blend of silver alginate fibers with cellulose ethyl sulfonate fibers using the techniques as generally set forth in WO 02/24240, which is incorporated by reference.
  • Calcium alginate fibers containing approximately 24% by weight silver were manufactured by immersing calcium alginate fibers in a mixture of water/acetone/silver nitrate, followed by washing in acetone/water and finally acetone before drying the fibers at 50° C. These fibers were cut to 50 mm staple and blended with cellulose ethyl sulfonate staple fibers in such a ratio to give approximately 1.5% silver on weight of dressing, then the blend carded and needle-bonded to give approximately 100 gsm needled fabric. The fabric had an off-white color on prolonged exposure to light.
  • In a surface antimicrobial efficacy test known as Qualiscreen, the dressing was found to be antimicrobial, i.e., inhibited formation of greater than 99.9% of daughter cells (methicillin resistant Staphylococcus aureus).
  • Example 13 PHMB Cellulose Ethyl Sulfonate
  • In this example, a PHMB-loaded cellulose ethyl sulfonate fabric was produced by the spray method using a 20% aqueous solution of PHMB to give 0.6% PHMB by weight on dressing. A sample of the dressing was subjected to the “milk test.” The dressing remained antimicrobial for 72 hours, while the control sample became populated with microbes after 24 hours.
  • Example 14 Low Gel Non-Adherent Contact Layer Dressing
  • Cellulose ethylsulphonate fibers with a fiber absorbency of 4.7 g/g as measured by the method in Example 1 were cut to 50 mm staple, then carded and needled to give a fabric. The absorbency of this fabric was measured by weighing a 5 cm×5 cm square of sample material (W1). Next, the sample was placed in Solution A (sodium/calcium solution) at 37° C. for 30 minutes in a petri-dish. Then the square was lifted out of the petri-dish by holding the square by one corner, and the sample was allowed to drain for 30 seconds, then the sample was reweighed (W2). The fabric absorbency is given by W2−W1/W1.
  • The wet strength was measured by cutting test specimens 2.5 cm wide×10 cm long from the fabric. The sample was mounted in an Instron 3343 tensile testing machine to give a gauge length 5 cm. The sample was then wetted with 2.5 ml of solution A (sodium/calcium solution), left for one minute, and then tested at 100 mm/min.
  • A highly absorbent fabric from Example 11, prepared from cellulose ethylsulphonate fibers with an fiber free absorbency of 12.9 g/g served as a comparison. The absorbency and tensile strength results are shown in the table below:
  • TABLE 5
    Fabric
    Strength Absorbency
    (N/cm) (g/g)
    Low gel non-adherent contact layer 1.32 16.8
    cellulose ethylsulphonate fabric
    Highly absorbent cellulose 0.4 19.4
    ethylsulphonate fabric (Example 11) --
    unreinforced
  • It can be seen that absorbency is compromised in the case of the contact layer fabric, but wet strength is significantly improved. Furthermore the contact layer fabric exhibited a slippery feel suggesting a low adherence to skin.
  • From the foregoing it will be seen that this invention is one well adapted to attain all ends and objectives herein-above set forth, together with the other advantages which are obvious and which are inherent to the invention. Since many possible embodiments may be made of the invention without departing from the scope thereof, it is to be understood that all matters herein set forth or shown in the accompanying drawing are to be interpreted as illustrative, and not in a limiting sense. While specific embodiments have been shown and discussed, various modifications may, of course, be made, and the invention is not limited to the specific forms or arrangement of parts and steps described herein, except insofar as such limitations are included in the following claims. Further, it will be understood that certain features and subcombinations are of utility and may be employed without reference to other features and subcombinations. This is contemplated by and is within the scope of the claims.

Claims (33)

What is claimed and desired to be secured by Letters Patent is as follows:
1. A non-woven absorbent fabric comprising:
a gelling fiber; and
a reinforcing fiber comprising between 4 and 30 weight percent of the fabric, wherein the gelling fiber is blended or bonded with the reinforcing fiber within the non-woven fabric.
2. The non-woven absorbent fabric of claim 1, wherein the absorbency of the fabric is not lower than the absorbency of a fabric comprising the gelling fiber without the reinforcing fiber.
3. The non-woven absorbent fabric of claim 1, wherein the absorbency of the fabric is at least 15 g/g.
4. The non-woven absorbent fabric of claim 1, wherein the wet strength of the fabric is at least 0.6 N/cm.
5. The non-woven absorbent fabric of claim 4, wherein the wet strength of the fabric is at least 1 N/cm.
6. The non-woven absorbent fabric of claim 5, wherein the wet strength of the fabric is at least 2 N/cm.
7. The non-woven absorbent fabric of claim 1, wherein the wet strength of the fabric is greater than the wet strength of a non-woven fabric comprising the gelling fiber without the reinforcing fiber.
8. The non-woven absorbent fabric of claim 7, wherein the reinforcing fiber comprises between 10 and 30 weight percent of the fabric.
9. The non-woven absorbent fabric of claim 1, wherein the reinforcing fiber has a linear density between 0.7 and 30 decitex.
10. The non-woven absorbent fabric of claim 9, wherein the reinforcing fiber has a linear density between 0.7 and 4.0 decitex.
11. The non-woven absorbent fabric of claim 1, wherein said reinforcing fiber comprises a thermoplastic biocomponent fiber that is thermally bonded to said gelling fiber.
12. The non-woven absorbent fabric of claim 1, wherein the gelling fiber is a polysaccharide fiber.
13. The non-woven absorbent fabric of claim 12, wherein said reinforcing fiber comprises a cellulosic fiber.
14. The non-woven absorbent fabric of claim 13, wherein said reinforcing fiber comprises a solvent spun cellulose fiber.
15. The non-woven absorbent fabric of claim 14, wherein said solvent spun cellulose fiber comprises 10 to 30 weight percent of the fabric and has a linear density of 0.7 to 30 decitex.
16. The non-woven absorbent fabric of claim 12, where in the gelling fiber is a polysaccharide alkyl sulfonate.
17. The non-woven absorbent fabric of claim 1, wherein the gelling fiber is derived from the group consisting of alginic acid, carboxymethylcellulose, carboxymethylchitosan, and salts thereof.
18. The non-woven absorbent fabric of claim 1, wherein the gelling fiber has a fiber free absorbency of 0.9% saline solution as a test liquid of at least 8 g/g.
19. The non-woven absorbent fabric of claim 1, wherein the gelling fiber has a fiber free absorbency of 0.9% saline solution as a test liquid of at least 2 g/g.
20. A non-woven absorbent fabric comprising:
a gelling fiber; and
a reinforcing fiber, wherein the absorbency of the fabric is not lower than the absorbency of a fabric comprising the gelling fiber without the reinforcing fiber.
21. The non-woven absorbent fabric of claim 20, wherein the absorbency of the fabric is at least 15 g/g.
22. The non-woven absorbent fabric of claim 21, wherein the reinforcing fiber has a linear density between 0.7 and 30 decitex.
23. The non-woven absorbent fabric of claim 22, wherein the reinforcing fiber has a linear density between 0.7 and 4.0 decitex.
24. The non-woven absorbent fabric of claim 20, wherein said reinforcing fiber comprises a thermoplastic biocomponent fiber that is thermally bonded to said gelling fiber.
25. The non-woven absorbent fabric of claim 20, wherein the gelling fiber is a polysaccharide fiber.
26. The non-woven absorbent fabric of claim 25, wherein said reinforcing fiber comprises a cellulosic fiber.
27. The non-woven absorbent fabric of claim 26, wherein said reinforcing fiber comprises a solvent spun cellulose fiber.
28. The non-woven absorbent fabric of claim 27, wherein said solvent spun cellulose fiber comprises 10 to 30 weight percent of the fabric and has a linear density of 0.7 to 30 decitex.
29. The non-woven absorbent fabric of claim 25, where in the gelling fiber is a polysaccharide alkyl sulfonate.
30. The non-woven absorbent fabric of claim 20, wherein the gelling fiber is derived from the group consisting of alginic acid, carboxymethylcellulose, carboxymethylchitosan, and salts thereof.
31. The non-woven absorbent fabric of claim 20, wherein the gelling fiber has a fiber free absorbency of 0.9% saline solution as a test liquid of at least 8 g/g.
32. The non-woven absorbent fabric of claim 20, wherein the gelling fiber has a fiber free absorbency of 0.9% saline solution as a test liquid of at least 2 g/g.
33. A process for forming a non-woven absorbent fabric comprising:
blending a gelling fiber with a reinforcing fiber through a card to form a fiber web, wherein the reinforcing fiber comprises no more than 30 weight percent of the fiber web;
forming a non-woven fabric by needlebonding or thermally bonding the fiber web.
US14/941,906 2008-11-27 2015-11-16 Absorbent material Abandoned US20160114074A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/941,906 US20160114074A1 (en) 2008-11-27 2015-11-16 Absorbent material

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0821675.6 2008-11-27
GB0821675A GB0821675D0 (en) 2008-11-27 2008-11-27 Absorbent material
EP08171355.4 2008-12-11
EP08171355A EP2196224A1 (en) 2008-12-11 2008-12-11 Absorbent material
US12/574,322 US9221963B2 (en) 2008-11-27 2009-10-06 Absorbent material
US14/941,906 US20160114074A1 (en) 2008-11-27 2015-11-16 Absorbent material

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12/574,322 Continuation US9221963B2 (en) 2008-11-27 2009-10-06 Absorbent material

Publications (1)

Publication Number Publication Date
US20160114074A1 true US20160114074A1 (en) 2016-04-28

Family

ID=42224337

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/574,322 Active 2031-07-04 US9221963B2 (en) 2008-11-27 2009-10-06 Absorbent material
US14/941,906 Abandoned US20160114074A1 (en) 2008-11-27 2015-11-16 Absorbent material

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US12/574,322 Active 2031-07-04 US9221963B2 (en) 2008-11-27 2009-10-06 Absorbent material

Country Status (13)

Country Link
US (2) US9221963B2 (en)
EP (1) EP2376132B1 (en)
JP (1) JP5581328B2 (en)
KR (1) KR101679440B1 (en)
CN (2) CN102292112B (en)
AU (1) AU2009321305B2 (en)
BR (1) BRPI0920905B1 (en)
CA (1) CA2744465C (en)
IL (1) IL213067A (en)
RU (2) RU2011126177A (en)
SG (1) SG10201406075RA (en)
WO (1) WO2010061225A2 (en)
ZA (1) ZA201103830B (en)

Cited By (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9884137B2 (en) 2012-10-05 2018-02-06 Speciality Fibres And Materials Limited Absorbent materials
WO2018125993A1 (en) * 2016-12-28 2018-07-05 Kci Usa, Inc. Antimicrobial wound dressings
WO2018189265A1 (en) 2017-04-11 2018-10-18 Smith & Nephew Plc Component positioning and stress relief for sensor enabled wound dressings
WO2018210692A1 (en) 2017-05-15 2018-11-22 Smith & Nephew Plc Wound analysis device and method
WO2018210693A1 (en) 2017-05-15 2018-11-22 Smith & Nephew Plc Negative pressure wound therapy system using eulerian video magnification
WO2018234443A1 (en) 2017-06-23 2018-12-27 Smith & Nephew Plc Positioning of sensors for sensor enabled wound monitoring or therapy
WO2019020551A1 (en) 2017-07-25 2019-01-31 Smith & Nephew Plc Skewing pads for impedance measurement
WO2019020550A2 (en) 2017-07-25 2019-01-31 Smith & Nephew Plc Biocompatible encapsulation and component stress relief for sensor enabled negative pressure wound therapy dressings
WO2019020666A1 (en) 2017-07-25 2019-01-31 Smith & Nephew Plc Restriction of sensor-monitored region for sensor-enabled wound dressings
WO2019030384A2 (en) 2017-08-10 2019-02-14 Smith & Nephew Plc Positioning of sensors for sensor enabled wound monitoring or therapy
WO2019048626A1 (en) 2017-09-10 2019-03-14 Smith & Nephew Plc Electrostatic discharge protection for sensors in wound therapy
WO2019048624A1 (en) 2017-09-10 2019-03-14 Smith & Nephew Plc Systems and methods for inspection of encapsulation and components in sensor equipped wound dressings
WO2019063481A1 (en) 2017-09-27 2019-04-04 Smith & Nephew Plc Ph sensing for sensor enabled negative pressure wound monitoring and therapy apparatuses
WO2019072531A1 (en) 2017-09-28 2019-04-18 Smith & Nephew Plc Neurostimulation and monitoring using sensor enabled wound monitoring and therapy apparatus
WO2019076967A2 (en) 2017-10-18 2019-04-25 Smith & Nephew Plc Fluid management for sensor enabled wound therapy dressings and systems
WO2019243171A1 (en) 2018-06-18 2019-12-26 T.J.Smith And Nephew,Limited Foot loading monitoring apparatus
WO2020043806A1 (en) 2018-08-29 2020-03-05 Smith & Nephew Plc Component positioning and encapsulation for sensor enabled wound dressings
WO2020053290A1 (en) 2018-09-12 2020-03-19 Smith & Nephew Plc Device, apparatus and method of determining skin perfusion pressure
US10603218B2 (en) * 2012-12-28 2020-03-31 Foshan United Medical Technologies, Ltd. Chemically modified seacell fibres, wound dressing made therefrom and preparation method thereof
WO2020064937A1 (en) 2018-09-28 2020-04-02 T.J.Smith And Nephew,Limited Optical fibers for optically sensing through wound dressings
WO2020078978A2 (en) 2018-10-16 2020-04-23 Smith & Nephew Plc Systems and method for applying biocompatible encapsulation to sensor enabled wound monitoring and therapy dressings
WO2020078993A1 (en) 2018-10-18 2020-04-23 T.J.Smith And Nephew,Limited Tissue treatment device
WO2020079009A1 (en) 2018-10-19 2020-04-23 T.J.Smith And Nephew,Limited Tissue treatment device
GB202003586D0 (en) 2020-03-12 2020-04-29 Smith & Nephew Device, apparatus and method of determining skin perfusion pressure
WO2020104426A1 (en) 2018-11-19 2020-05-28 T.J.Smith And Nephew,Limited Absorbent component
WO2020104440A1 (en) 2018-11-19 2020-05-28 T.J.Smith And Nephew,Limited Method of immobilising a protein on a substrate
WO2020104427A1 (en) 2018-11-19 2020-05-28 T.J.Smith And Nephew,Limited Absorbent yarn
WO2020157103A1 (en) 2019-01-30 2020-08-06 Smith & Nephew Plc Sensor integrated dressings and systems
WO2020157066A1 (en) 2019-01-30 2020-08-06 Smith & Nephew Plc Optical sensing systems and methods for sensor enabled wound dressings and systems
WO2020187851A1 (en) 2019-03-18 2020-09-24 Smith & Nephew Plc Design rules for sensor integrated substrates
WO2020187643A1 (en) 2019-03-19 2020-09-24 Smith & Nephew Plc Systems and methods for measuring tissue impedance
WO2021005036A1 (en) 2019-07-11 2021-01-14 Smith & Nephew Plc Sensor sheet with digital distributed data acquisition for wound monitoring and treatment
WO2021032720A1 (en) 2019-08-22 2021-02-25 T.J.Smith And Nephew,Limited Wound dressing
WO2021032713A1 (en) 2019-08-22 2021-02-25 T.J.Smith And Nephew,Limited Absorbent component
GB202100527D0 (en) 2021-01-15 2021-03-03 Smith & Nephew Systems and methods for managing operation of wound dressings or wound treatment devices
WO2021069286A1 (en) 2019-10-07 2021-04-15 Smith & Nephew Plc Sensor enabled negative pressure wound monitoring apparatus with different impedances inks
WO2021078721A1 (en) 2019-10-22 2021-04-29 T.J.Smith And Nephew,Limited Pressure injury prevention and treatment using redirection in a virtual reality, augmented reality, or mixed reality environment
WO2021123014A1 (en) 2019-12-19 2021-06-24 Smith & Nephew Plc Sensor integrated dressings and systems
WO2021122701A1 (en) 2019-12-16 2021-06-24 T.J.Smith And Nephew,Limited Monitoring and therapy devices and methods of using same
WO2021175977A1 (en) 2020-03-05 2021-09-10 Smith & Nephew Plc Sensor integrated dressings and systems
WO2021214203A1 (en) 2020-04-22 2021-10-28 T.J.Smith And Nephew,Limited Tissue treatment device
US11584111B2 (en) 2018-11-05 2023-02-21 Windmoeller & Hoelscher Kg Breathable thermoplastic film with reduced shrinkage

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525504D0 (en) 2005-12-14 2006-01-25 Bristol Myers Squibb Co Antimicrobial composition
KR101070358B1 (en) 2009-12-24 2011-10-05 한국생산기술연구원 Surgical nonwoven material and manufacturing method thereof
CN102462860A (en) * 2010-11-10 2012-05-23 广东百合医疗科技有限公司 Fiber wound dressing with antibacterial effect and preparation method thereof
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
CN102743786B (en) * 2011-04-20 2015-03-18 佛山市优特医疗科技有限公司 Wound dressing having bacteriostasis and hygroscopicity
KR101798060B1 (en) 2011-06-03 2017-11-15 삼성전자주식회사 surgical device
GB201109991D0 (en) * 2011-06-14 2011-07-27 Lantor Uk Ltd Process and device
GB201209745D0 (en) 2012-05-31 2012-07-18 Convatec Technologies Inc Wound dressing
KR20150099776A (en) * 2012-12-20 2015-09-01 컨바텍 테크놀러지스 인크 Processing of chemically modified cellulosic fibres
JP2016529939A (en) * 2013-06-12 2016-09-29 キンバリー クラーク ワールドワイド インコーポレイテッド Absorbent articles comprising a nonwoven web formed from porous polyolefin fibers
CN103755817B (en) * 2013-12-11 2016-08-17 江苏科技大学 A kind of preparation method of nano micro crystal cellulose
WO2018184050A1 (en) 2017-04-03 2018-10-11 Lenzing Ag A nonwoven web designed for use in a wound care product
CN108498842B (en) * 2018-05-15 2021-01-05 唐山市博世德医疗器械有限公司 Medical dressing for in vitro wound care and preparation method thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4834735A (en) * 1986-07-18 1989-05-30 The Proctor & Gamble Company High density absorbent members having lower density and lower basis weight acquisition zones
US5681300A (en) * 1991-12-17 1997-10-28 The Procter & Gamble Company Absorbent article having blended absorbent core
WO2001052911A2 (en) * 2000-01-19 2001-07-26 Weyerhaeuser Company Superabsorbent cellulosic fiber
US20030012919A1 (en) * 1999-01-11 2003-01-16 Dutkiewicz Jacek K. High-performance absorbent structure
US20030181884A1 (en) * 1997-11-13 2003-09-25 The Procter & Gamble Company Highly efficient absorbent article for use with menstrual pant
US20040030314A1 (en) * 1997-03-27 2004-02-12 The Procter & Gamble Company Disposable absorbent articles having multiple absorbent core components including replaceable components
US20050288647A1 (en) * 2004-06-29 2005-12-29 Ellingson Alissa R Topographical composite liners
US20060253093A1 (en) * 2001-07-23 2006-11-09 The Procter & Gamble Company Disposable absorbent articles having multiple absorbent core components including replaceable components

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2580352A (en) 1949-03-31 1951-12-25 Hercules Powder Co Ltd Preparation of sulfoethyl ethers of polysaccharides
US2811519A (en) 1954-02-05 1957-10-29 Eastman Kodak Co Mixed cellulose ethers and their preparation
GB769799A (en) 1954-08-30 1957-03-13 Permachem Corp Improvements in or relating to articles treated so as to have microbicidal properties
GB813900A (en) 1956-11-09 1959-05-27 Mo Och Domsjoe Ab Sulphomethylcelluloses
GB1073183A (en) 1963-02-05 1967-06-21 Ici Ltd Leather-like materials
DD53043A (en) 1963-03-01 1900-01-01
GB1207352A (en) 1967-10-16 1970-09-30 David Torr Disposable absorbent products
US4200557A (en) 1973-12-07 1980-04-29 Personal Products Company Absorbent product including grafted insolubilized cellulose ether
CA1045127A (en) 1975-05-27 1978-12-26 Robert F. Schwenker (Jr.) Absorbent cellulosic product
US4783448A (en) 1983-06-07 1988-11-08 Perstorp Ab Method for cleansing an infected sore
DE3408131A1 (en) * 1984-03-06 1985-09-12 Chemiefaser Lenzing Ag, Lenzing DESODORING AND MICROBISTATIC FIBER MATERIAL
EP0171806A3 (en) 1984-08-16 1987-06-16 Chicopee An entangled nonwoven fabric including bicomponent fibers and the method of making same
EP0172437B1 (en) * 1984-08-18 1989-09-06 Akzo Patente GmbH Modified cellulose dialysis membrane with improved biocompatibility
US4818598A (en) 1985-06-28 1989-04-04 The Procter & Gamble Company Absorbent structures
DE3742104A1 (en) 1987-12-11 1989-06-22 Wolff Walsrode Ag SULFOETHYL CELLULOSE WITH EXCELLENT SOLUTION QUALITY AND METHOD FOR THE PRODUCTION THEREOF
DK245488D0 (en) 1988-05-05 1988-05-05 Danaklon As SYNTHETIC FIBER AND PROCEDURES FOR PRODUCING THEREOF
US5252340A (en) 1989-12-14 1993-10-12 Isolyser Company, Inc. Method of producing an absorbent composition
JPH04117401A (en) 1990-09-07 1992-04-17 Dic Hercules Chem Inc Production of sulfonated chitosan
DE4113892A1 (en) 1991-04-27 1992-10-29 Wolff Walsrode Ag WATER-SOLUBLE SULFOETHYLCELLULOSE ETHER WITH A VERY GOOD SOLUTION QUALITY AND METHOD FOR THE PRODUCTION THEREOF
GB9126193D0 (en) 1991-12-10 1992-02-12 Courtaulds Plc Cellulosic fibres
BR9206996A (en) 1991-12-30 1995-12-05 Fmc Corp Suitable composition for preparing spheroids by spheroidization process to produce a particulate material process to produce a spheroidized solid particulate dosage form and solid dosage form
DE4243281A1 (en) 1992-12-21 1994-06-23 Wolff Walsrode Ag Highly substituted sulfoalkyl cellulose derivatives, especially sulfoethyl cellulose ethers, processes for their preparation and their use as thickeners for textile printing ink pastes
WO1994016746A1 (en) 1993-01-22 1994-08-04 Courtaulds Plc Wound dressings
GB9400994D0 (en) 1994-01-20 1994-03-16 Bristol Myers Squibb Co Wound dressing
EP0665311B1 (en) 1994-01-29 1998-12-09 DyStar Textilfarben GmbH & Co. Deutschland KG Aminated cellulosic synthetic fibers
US5522967A (en) 1994-05-27 1996-06-04 Kimberly-Clark Corporation Sulfonated cellulose and method of preparation
DE19549409A1 (en) 1995-05-24 1997-01-02 Hoechst Ag Sulphonated regenerated cellulose fibre and vinyl] sulphonic starch
US5703225A (en) 1995-12-13 1997-12-30 Kimberly-Clark Worldwide, Inc. Sulfonated cellulose having improved absorbent properties
DE19628617A1 (en) 1996-07-16 1998-01-22 Basf Ag Direct tabletting aid
US5981410A (en) * 1997-04-08 1999-11-09 Fibervisions A/S Cellulose-binding fibres
US6605751B1 (en) 1997-11-14 2003-08-12 Acrymed Silver-containing compositions, devices and methods for making
US6716895B1 (en) * 1999-12-15 2004-04-06 C.R. Bard, Inc. Polymer compositions containing colloids of silver salts
US6444214B1 (en) * 2000-05-04 2002-09-03 Kimberly-Clark Worldwide, Inc. Ion-sensitive, water-dispersible polymers, a method of making same and items using same
GB2370226A (en) 2000-09-21 2002-06-26 Acordis Speciality Fibres Ltd Wound dressing
CN1568191A (en) 2000-11-29 2005-01-19 布里斯托尔-迈尔斯斯奎布公司 Light stabilized antimicrobial materials
HUP0303178A3 (en) 2001-02-05 2008-03-28 R P Scherer Technologies Methods and compositions for reducing the taste of pharmaceutically active agents
US6500947B1 (en) 2001-08-24 2002-12-31 Weyerhaeuser Company Superabsorbent polymer
US20050058683A1 (en) * 2003-09-12 2005-03-17 Levy Ruth L. Absorbent articles with antimicrobial zones on coverstock
US20050283004A1 (en) 2004-06-18 2005-12-22 Hopax Chemicals Manufacturing Co., Ltd. Alkylsulfonated polyaminosaccharides
WO2006034249A2 (en) 2004-09-20 2006-03-30 Acrymed, Inc. Antimicrobial amorphous compositions
US20060142560A1 (en) 2004-12-29 2006-06-29 Glasser Wolfgang G Sulfoalkylated cellulose
US20060142484A1 (en) 2004-12-29 2006-06-29 Glasser Wolfgang G Sulfoalkylated cellulose polymer network
US20060142477A1 (en) 2004-12-29 2006-06-29 Glasser Wolfgang G Method for making sulfoalkylated cellulose polymer network
WO2008057267A2 (en) 2006-10-27 2008-05-15 Fmc Corporation Co-processed microcrystalline cellulose and sugar alcohol as an excipient for tablet formulations
US20080147026A1 (en) 2006-12-15 2008-06-19 Jian Qin Absorbent fiber with a low absorbent capacity and slow absorption rate
JP2009018260A (en) 2007-07-12 2009-01-29 Toyota Motor Corp Method apparatus for cleaning by plasma exited gas
US20090259157A1 (en) * 2008-04-14 2009-10-15 Tom Thomas Method for imparting antimicrobial characteristics to hydrophilic fabrics

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4834735A (en) * 1986-07-18 1989-05-30 The Proctor & Gamble Company High density absorbent members having lower density and lower basis weight acquisition zones
US5681300A (en) * 1991-12-17 1997-10-28 The Procter & Gamble Company Absorbent article having blended absorbent core
US20040030314A1 (en) * 1997-03-27 2004-02-12 The Procter & Gamble Company Disposable absorbent articles having multiple absorbent core components including replaceable components
US20030181884A1 (en) * 1997-11-13 2003-09-25 The Procter & Gamble Company Highly efficient absorbent article for use with menstrual pant
US20030012919A1 (en) * 1999-01-11 2003-01-16 Dutkiewicz Jacek K. High-performance absorbent structure
WO2001052911A2 (en) * 2000-01-19 2001-07-26 Weyerhaeuser Company Superabsorbent cellulosic fiber
US20060253093A1 (en) * 2001-07-23 2006-11-09 The Procter & Gamble Company Disposable absorbent articles having multiple absorbent core components including replaceable components
US20050288647A1 (en) * 2004-06-29 2005-12-29 Ellingson Alissa R Topographical composite liners

Cited By (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9884137B2 (en) 2012-10-05 2018-02-06 Speciality Fibres And Materials Limited Absorbent materials
US10603218B2 (en) * 2012-12-28 2020-03-31 Foshan United Medical Technologies, Ltd. Chemically modified seacell fibres, wound dressing made therefrom and preparation method thereof
CN110461376A (en) * 2016-12-28 2019-11-15 希丝塔杰尼斯创伤护理有限公司 Antimicrobial wound dressing
WO2018125993A1 (en) * 2016-12-28 2018-07-05 Kci Usa, Inc. Antimicrobial wound dressings
WO2018189265A1 (en) 2017-04-11 2018-10-18 Smith & Nephew Plc Component positioning and stress relief for sensor enabled wound dressings
WO2018210692A1 (en) 2017-05-15 2018-11-22 Smith & Nephew Plc Wound analysis device and method
WO2018210693A1 (en) 2017-05-15 2018-11-22 Smith & Nephew Plc Negative pressure wound therapy system using eulerian video magnification
WO2018234443A1 (en) 2017-06-23 2018-12-27 Smith & Nephew Plc Positioning of sensors for sensor enabled wound monitoring or therapy
WO2019020551A1 (en) 2017-07-25 2019-01-31 Smith & Nephew Plc Skewing pads for impedance measurement
WO2019020666A1 (en) 2017-07-25 2019-01-31 Smith & Nephew Plc Restriction of sensor-monitored region for sensor-enabled wound dressings
WO2019020550A2 (en) 2017-07-25 2019-01-31 Smith & Nephew Plc Biocompatible encapsulation and component stress relief for sensor enabled negative pressure wound therapy dressings
EP4346340A2 (en) 2017-07-25 2024-04-03 Smith & Nephew PLC Biocompatible encapsulation and component stress relief for sensor enabled negative pressure wound therapy dressings
WO2019030384A2 (en) 2017-08-10 2019-02-14 Smith & Nephew Plc Positioning of sensors for sensor enabled wound monitoring or therapy
WO2019048626A1 (en) 2017-09-10 2019-03-14 Smith & Nephew Plc Electrostatic discharge protection for sensors in wound therapy
WO2019048624A1 (en) 2017-09-10 2019-03-14 Smith & Nephew Plc Systems and methods for inspection of encapsulation and components in sensor equipped wound dressings
WO2019063481A1 (en) 2017-09-27 2019-04-04 Smith & Nephew Plc Ph sensing for sensor enabled negative pressure wound monitoring and therapy apparatuses
WO2019072531A1 (en) 2017-09-28 2019-04-18 Smith & Nephew Plc Neurostimulation and monitoring using sensor enabled wound monitoring and therapy apparatus
WO2019076967A2 (en) 2017-10-18 2019-04-25 Smith & Nephew Plc Fluid management for sensor enabled wound therapy dressings and systems
WO2019243171A1 (en) 2018-06-18 2019-12-26 T.J.Smith And Nephew,Limited Foot loading monitoring apparatus
WO2020043806A1 (en) 2018-08-29 2020-03-05 Smith & Nephew Plc Component positioning and encapsulation for sensor enabled wound dressings
WO2020053290A1 (en) 2018-09-12 2020-03-19 Smith & Nephew Plc Device, apparatus and method of determining skin perfusion pressure
WO2020064937A1 (en) 2018-09-28 2020-04-02 T.J.Smith And Nephew,Limited Optical fibers for optically sensing through wound dressings
WO2020078978A2 (en) 2018-10-16 2020-04-23 Smith & Nephew Plc Systems and method for applying biocompatible encapsulation to sensor enabled wound monitoring and therapy dressings
WO2020078993A1 (en) 2018-10-18 2020-04-23 T.J.Smith And Nephew,Limited Tissue treatment device
WO2020079009A1 (en) 2018-10-19 2020-04-23 T.J.Smith And Nephew,Limited Tissue treatment device
US11584111B2 (en) 2018-11-05 2023-02-21 Windmoeller & Hoelscher Kg Breathable thermoplastic film with reduced shrinkage
WO2020104426A1 (en) 2018-11-19 2020-05-28 T.J.Smith And Nephew,Limited Absorbent component
WO2020104440A1 (en) 2018-11-19 2020-05-28 T.J.Smith And Nephew,Limited Method of immobilising a protein on a substrate
WO2020104427A1 (en) 2018-11-19 2020-05-28 T.J.Smith And Nephew,Limited Absorbent yarn
WO2020157103A1 (en) 2019-01-30 2020-08-06 Smith & Nephew Plc Sensor integrated dressings and systems
WO2020157066A1 (en) 2019-01-30 2020-08-06 Smith & Nephew Plc Optical sensing systems and methods for sensor enabled wound dressings and systems
WO2020187851A1 (en) 2019-03-18 2020-09-24 Smith & Nephew Plc Design rules for sensor integrated substrates
WO2020187643A1 (en) 2019-03-19 2020-09-24 Smith & Nephew Plc Systems and methods for measuring tissue impedance
WO2021005036A1 (en) 2019-07-11 2021-01-14 Smith & Nephew Plc Sensor sheet with digital distributed data acquisition for wound monitoring and treatment
WO2021032713A1 (en) 2019-08-22 2021-02-25 T.J.Smith And Nephew,Limited Absorbent component
WO2021032720A1 (en) 2019-08-22 2021-02-25 T.J.Smith And Nephew,Limited Wound dressing
WO2021069286A1 (en) 2019-10-07 2021-04-15 Smith & Nephew Plc Sensor enabled negative pressure wound monitoring apparatus with different impedances inks
WO2021078721A1 (en) 2019-10-22 2021-04-29 T.J.Smith And Nephew,Limited Pressure injury prevention and treatment using redirection in a virtual reality, augmented reality, or mixed reality environment
WO2021122701A1 (en) 2019-12-16 2021-06-24 T.J.Smith And Nephew,Limited Monitoring and therapy devices and methods of using same
WO2021123014A1 (en) 2019-12-19 2021-06-24 Smith & Nephew Plc Sensor integrated dressings and systems
WO2021175977A1 (en) 2020-03-05 2021-09-10 Smith & Nephew Plc Sensor integrated dressings and systems
WO2021180947A1 (en) 2020-03-12 2021-09-16 Smith & Nephew Plc Device, apparatus and method of determining skin perfusion pressure
GB202003586D0 (en) 2020-03-12 2020-04-29 Smith & Nephew Device, apparatus and method of determining skin perfusion pressure
WO2021214203A1 (en) 2020-04-22 2021-10-28 T.J.Smith And Nephew,Limited Tissue treatment device
GB202100527D0 (en) 2021-01-15 2021-03-03 Smith & Nephew Systems and methods for managing operation of wound dressings or wound treatment devices
WO2022152618A1 (en) 2021-01-15 2022-07-21 T.J.Smith And Nephew,Limited Systems and methods for managing operation of wound dressings or wound treatment devices

Also Published As

Publication number Publication date
CA2744465C (en) 2017-09-19
JP2012509731A (en) 2012-04-26
KR101679440B1 (en) 2016-11-24
JP5581328B2 (en) 2014-08-27
BRPI0920905A2 (en) 2017-05-30
RU2011126177A (en) 2013-01-10
ZA201103830B (en) 2016-08-31
WO2010061225A2 (en) 2010-06-03
CN102292112A (en) 2011-12-21
US20100129633A1 (en) 2010-05-27
CA2744465A1 (en) 2010-06-03
WO2010061225A3 (en) 2010-08-12
IL213067A (en) 2016-11-30
US9221963B2 (en) 2015-12-29
IL213067A0 (en) 2011-07-31
BRPI0920905B1 (en) 2018-10-30
CN104623717A (en) 2015-05-20
RU2014122324A (en) 2015-12-10
EP2376132B1 (en) 2019-02-27
EP2376132A2 (en) 2011-10-19
KR20110110134A (en) 2011-10-06
CN102292112B (en) 2015-06-10
AU2009321305B2 (en) 2015-10-29
RU2669557C2 (en) 2018-10-12
AU2009321305A1 (en) 2010-06-03
SG10201406075RA (en) 2014-11-27

Similar Documents

Publication Publication Date Title
US9221963B2 (en) Absorbent material
KR100320636B1 (en) Wound Protector
JP4499669B2 (en) Trauma bandage
JP5612551B2 (en) Manufacture of wound care products and materials suitable for their use
CN111108241A (en) Nonwoven web comprising polysaccharide
CN104768584A (en) Absorbent materials
US9144625B2 (en) Cellulose ethylsulfonate-based absorbent material
AU2017218300B2 (en) Sheet for covering wound
EP2196224A1 (en) Absorbent material
AU2015203676A1 (en) Absorbent Material
EP2663687A1 (en) Process for the manufacture of a dressing and dressing obtained

Legal Events

Date Code Title Description
AS Assignment

Owner name: SPECIALITY FIBRES AND MATERIALS LTD., UNITED KINGD

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LAW, STEPHEN;REEL/FRAME:037046/0600

Effective date: 20091002

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCV Information on status: appeal procedure

Free format text: NOTICE OF APPEAL FILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION